| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.893 | 0 | 0.922 | Anabolic | 0.661 0.001 DB00624 0.182 0.007 DBMET03460 0.847 0 DBMET03459 0.575 0.001 DBMET00558 0.392 0.001 DBMET02381 0.392 0.001 DBMET02382 0.236 0.002 DBMET00571 0.922 0 DBMET00574 0.392 0.001 DBMET02833 0.392 0.001 DBMET02834 | DBMET00574 | |
| 0.894 | 0.003 | 0.918 | Cholesterol antagonist | 0.818 0.004 DB00624 0.727 0.006 DBMET03460 0.876 0.003 DBMET03459 0.788 0.004 DBMET00558 0.821 0.004 DBMET02381 0.821 0.004 DBMET02382 0.918 0.002 DBMET00571 0.892 0.003 DBMET00574 0.821 0.004 DBMET02833 0.821 0.004 DBMET02834 | DBMET00571 | |
| 0.852 | 0.005 | 0.852 | Caspase 9 stimulant | 0.776 0.014 DB00624 0.799 0.011 DBMET03460 0.851 0.005 DBMET03459 0.771 0.015 DBMET00558 0.807 0.01 DBMET02381 0.807 0.01 DBMET02382 0.814 0.009 DBMET00571 0.282 0.215 DBMET00574 0.807 0.01 DBMET02833 0.807 0.01 DBMET02834 | ||
| 0.848 | 0.01 | 0.911 | Transcription factor NF kappa B inhibitor | 0.8 0.013 DB00624 0.402 0.063 DBMET03460 0.833 0.011 DBMET03459 0.788 0.014 DBMET00558 0.725 0.018 DBMET02381 0.725 0.018 DBMET02382 0.911 0.005 DBMET00571 0.653 0.026 DBMET00574 0.725 0.018 DBMET02833 0.725 0.018 DBMET02834 | DBMET00571 | |
| 0.807 | 0.014 | 0.87 | Antiinflammatory | 0.841 0.01 DB00624 0.579 0.059 DBMET03460 0.769 0.02 DBMET03459 0.806 0.014 DBMET00558 0.829 0.012 DBMET02381 0.829 0.012 DBMET02382 0.87 0.007 DBMET00571 0.797 0.016 DBMET00574 0.829 0.012 DBMET02833 0.829 0.012 DBMET02834 | DBMET00571 | |
| 0.778 | 0.002 | 0.824 | Aromatase inhibitor | 0.824 0.002 DB00624 0.671 0.002 DBMET03459 0.715 0.002 DBMET00558 0.602 0.003 DBMET02381 0.602 0.003 DBMET02382 0.097 0.022 DBMET00571 0.662 0.002 DBMET00574 0.602 0.003 DBMET02833 0.602 0.003 DBMET02834 | DB00624 | |
| 0.759 | 0.003 | 0.827 | Anesthetic general | 0.788 0.003 DB00624 0.59 0.005 DBMET03460 0.806 0.002 DBMET03459 0.827 0.002 DBMET00558 0.808 0.002 DBMET02381 0.808 0.002 DBMET02382 0.809 0.002 DBMET00571 0.367 0.021 DBMET00574 0.808 0.002 DBMET02833 0.808 0.002 DBMET02834 | DBMET00558 | |
| 0.773 | 0.02 | 0.847 | Apoptosis agonist | 0.774 0.02 DB00624 0.414 0.107 DBMET03460 0.794 0.017 DBMET03459 0.799 0.017 DBMET00558 0.847 0.011 DBMET02381 0.847 0.011 DBMET02382 0.814 0.015 DBMET00571 0.677 0.034 DBMET00574 0.847 0.011 DBMET02833 0.847 0.011 DBMET02834 0.292 0.178 DBMET03176 | DBMET02834 | |
| 0.694 | 0.001 | 0.844 | Androgen agonist | 0.844 0.001 DB00624 0.082 0.023 DBMET03460 0.648 0.001 DBMET03459 0.799 0.001 DBMET00558 0.64 0.001 DBMET02381 0.64 0.001 DBMET02382 0.315 0.003 DBMET00571 0.69 0.001 DBMET00574 0.64 0.001 DBMET02833 0.64 0.001 DBMET02834 | DB00624 | |
| 0.649 | 0.002 | 0.726 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.726 0.002 DB00624 0.529 0.002 DBMET03459 0.625 0.002 DBMET00558 0.594 0.002 DBMET02381 0.594 0.002 DBMET02382 0.031 0.009 DBMET00571 0.103 0.004 DBMET00574 0.594 0.002 DBMET02833 0.594 0.002 DBMET02834 | DB00624 | |
| 0.647 | 0.003 | 0.834 | Androgen antagonist | 0.834 0.002 DB00624 0.097 0.049 DBMET03460 0.598 0.003 DBMET03459 0.788 0.002 DBMET00558 0.634 0.003 DBMET02381 0.634 0.003 DBMET02382 0.243 0.01 DBMET00571 0.346 0.006 DBMET00574 0.634 0.003 DBMET02833 0.634 0.003 DBMET02834 | DB00624 | |
| 0.644 | 0.006 | 0.644 | DNA damaging | 0.502 0.014 DB00624 0.334 0.046 DBMET03460 0.632 0.007 DBMET03459 0.49 0.015 DBMET00558 0.461 0.018 DBMET02381 0.461 0.018 DBMET02382 0.488 0.015 DBMET00571 0.204 0.112 DBMET00574 0.461 0.018 DBMET02833 0.461 0.018 DBMET02834 | ||
| 0.609 | 0.007 | 0.725 | Hypoxia-inducible factor 1 alpha inhibitor | 0.725 0.004 DB00624 0.203 0.148 DBMET03460 0.437 0.022 DBMET03459 0.607 0.007 DBMET00558 0.595 0.008 DBMET02381 0.595 0.008 DBMET02382 0.673 0.005 DBMET00571 0.302 0.064 DBMET00574 0.595 0.008 DBMET02833 0.595 0.008 DBMET02834 | DB00624 | |
| 0.594 | 0.02 | 0.879 | Aldehyde oxidase inhibitor | 0.879 0.004 DB00624 0.718 0.007 DBMET03460 0.48 0.036 DBMET03459 0.788 0.005 DBMET00558 0.794 0.004 DBMET02381 0.794 0.004 DBMET02382 0.204 0.102 DBMET00574 0.794 0.004 DBMET02833 0.794 0.004 DBMET02834 | DB00624 | |
| 0.585 | 0.015 | 0.621 | Immunosuppressant | 0.575 0.016 DB00624 0.533 0.025 DBMET03460 0.562 0.018 DBMET03459 0.547 0.021 DBMET00558 0.515 0.029 DBMET03175 0.559 0.019 DBMET02381 0.559 0.019 DBMET02382 0.621 0.011 DBMET00571 0.5 0.033 DBMET00574 0.559 0.019 DBMET02833 0.559 0.019 DBMET02834 0.521 0.027 DBMET03176 | DBMET00571 | |
| 0.557 | 0.004 | 0.567 | Interferon gamma antagonist | 0.541 0.004 DB00624 0.362 0.013 DBMET03460 0.511 0.005 DBMET03459 0.49 0.006 DBMET00558 0.458 0.008 DBMET02381 0.458 0.008 DBMET02382 0.567 0.003 DBMET00571 0.219 0.035 DBMET00574 0.458 0.008 DBMET02833 0.458 0.008 DBMET02834 | DBMET00571 | |
| 0.553 | 0.003 | 0.615 | Lipocortins synthesis antagonist | 0.615 0.002 DB00624 0.393 0.009 DBMET03460 0.52 0.003 DBMET03459 0.589 0.002 DBMET00558 0.612 0.002 DBMET02381 0.612 0.002 DBMET02382 0.455 0.005 DBMET00571 0.478 0.004 DBMET00574 0.612 0.002 DBMET02833 0.612 0.002 DBMET02834 | DB00624 | |
| 0.551 | 0.014 | 0.655 | Apoptosis antagonist | 0.573 0.012 DB00624 0.61 0.009 DBMET03460 0.551 0.014 DBMET03459 0.576 0.012 DBMET00558 0.647 0.005 DBMET02381 0.647 0.005 DBMET02382 0.655 0.005 DBMET00571 0.45 0.028 DBMET00574 0.647 0.005 DBMET02833 0.647 0.005 DBMET02834 | DBMET00571 | |
| 0.54 | 0.006 | 0.548 | P-glycoprotein inhibitor | 0.482 0.009 DB00624 0.152 0.114 DBMET03460 0.548 0.006 DBMET03459 0.486 0.009 DBMET00558 0.503 0.008 DBMET02381 0.503 0.008 DBMET02382 0.328 0.024 DBMET00571 0.148 0.12 DBMET00574 0.503 0.008 DBMET02833 0.503 0.008 DBMET02834 | DBMET03459 | |
| 0.536 | 0.006 | 0.753 | Diuretic | 0.688 0.004 DB00624 0.31 0.021 DBMET03460 0.437 0.011 DBMET03459 0.6 0.005 DBMET00558 0.506 0.007 DBMET02381 0.506 0.007 DBMET02382 0.712 0.004 DBMET00571 0.753 0.003 DBMET00574 0.506 0.007 DBMET02833 0.506 0.007 DBMET02834 | DBMET00574 | |
| 0.525 | 0.003 | 0.736 | Estrogen agonist | 0.683 0.003 DB00624 0.526 0.003 DBMET03459 0.701 0.003 DBMET00558 0.736 0.002 DBMET02381 0.736 0.002 DBMET02382 0.491 0.004 DBMET00571 0.677 0.003 DBMET00574 0.736 0.002 DBMET02833 0.736 0.002 DBMET02834 | DBMET02834 | |
| 0.523 | 0.005 | 0.692 | NOS3 expression enhancer | 0.692 0.003 DB00624 0.285 0.02 DBMET03459 0.489 0.005 DBMET00558 0.589 0.004 DBMET02381 0.589 0.004 DBMET02382 0.426 0.007 DBMET00571 0.25 0.027 DBMET00574 0.589 0.004 DBMET02833 0.589 0.004 DBMET02834 | DB00624 | |
| 0.524 | 0.008 | 0.585 | Interleukin agonist | 0.455 0.012 DB00624 0.52 0.008 DBMET03460 0.487 0.01 DBMET03459 0.415 0.017 DBMET00558 0.496 0.009 DBMET02381 0.496 0.009 DBMET02382 0.585 0.005 DBMET00571 0.496 0.009 DBMET02833 0.496 0.009 DBMET02834 | DBMET00571 | |
| 0.495 | 0.001 | 0.495 | 5-Alpha-reductase 1 inhibitor | 0.462 0.001 DB00624 0.096 0.005 DBMET03460 0.447 0.001 DBMET03459 0.404 0.002 DBMET00558 0.257 0.002 DBMET02381 0.257 0.002 DBMET02382 0.058 0.007 DBMET00571 0.105 0.004 DBMET00574 0.257 0.002 DBMET02833 0.257 0.002 DBMET02834 | ||
| 0.493 | 0.001 | 0.493 | 5-Alpha-reductase inhibitor | 0.431 0.002 DB00624 0.145 0.007 DBMET03460 0.468 0.001 DBMET03459 0.417 0.002 DBMET00558 0.354 0.002 DBMET02381 0.354 0.002 DBMET02382 0.321 0.003 DBMET00571 0.216 0.004 DBMET00574 0.354 0.002 DBMET02833 0.354 0.002 DBMET02834 | ||
| 0.492 | 0.009 | 0.537 | Interleukin 2 agonist | 0.517 0.006 DB00624 0.537 0.005 DBMET03460 0.426 0.02 DBMET03459 0.445 0.017 DBMET00558 0.472 0.012 DBMET02381 0.472 0.012 DBMET02382 0.502 0.008 DBMET00571 0.317 0.062 DBMET00574 0.472 0.012 DBMET02833 0.472 0.012 DBMET02834 | DBMET03460 | |
| 0.484 | 0.012 | 0.512 | Psychostimulant | 0.319 0.038 DB00624 0.512 0.01 DBMET03460 0.402 0.022 DBMET03459 0.235 0.064 DBMET00558 0.19 0.086 DBMET02381 0.19 0.086 DBMET02382 0.255 0.057 DBMET00571 0.19 0.086 DBMET02833 0.19 0.086 DBMET02834 | DBMET03460 | |
| 0.475 | 0.007 | 0.686 | Phospholipase C inhibitor | 0.388 0.011 DB00624 0.588 0.004 DBMET03460 0.632 0.004 DBMET03459 0.567 0.004 DBMET00558 0.364 0.013 DBMET03175 0.686 0.003 DBMET02381 0.686 0.003 DBMET02382 0.313 0.017 DBMET00571 0.544 0.005 DBMET00574 0.686 0.003 DBMET02833 0.686 0.003 DBMET02834 0.393 0.011 DBMET03176 | DBMET02834 | |
| 0.466 | 0.006 | 0.627 | Sodium/bile acid cotransporter inhibitor | 0.509 0.004 DB00624 0.45 0.007 DBMET03460 0.517 0.003 DBMET03459 0.566 0.002 DBMET00558 0.627 0.001 DBMET02381 0.627 0.001 DBMET02382 0.475 0.005 DBMET00571 0.515 0.003 DBMET00574 0.627 0.001 DBMET02833 0.627 0.001 DBMET02834 | DBMET02834 | |
| 0.486 | 0.031 | 0.791 | Immunostimulant | 0.429 0.042 DB00624 0.453 0.036 DBMET03460 0.497 0.029 DBMET03459 0.436 0.04 DBMET00558 0.779 0.005 DBMET03175 0.459 0.035 DBMET02381 0.459 0.035 DBMET02382 0.626 0.014 DBMET00571 0.511 0.028 DBMET00574 0.459 0.035 DBMET02833 0.459 0.035 DBMET02834 0.791 0.004 DBMET03176 | DBMET03176 | |
| 0.453 | 0.003 | 0.501 | Cholesterol synthesis inhibitor | 0.416 0.004 DB00624 0.318 0.01 DBMET03460 0.46 0.003 DBMET03459 0.423 0.004 DBMET00558 0.456 0.003 DBMET02381 0.456 0.003 DBMET02382 0.367 0.006 DBMET00571 0.501 0.002 DBMET00574 0.456 0.003 DBMET02833 0.456 0.003 DBMET02834 | DBMET00574 | |
| 0.456 | 0.019 | 0.69 | Nitric oxide antagonist | 0.539 0.013 DB00624 0.184 0.074 DBMET03460 0.531 0.014 DBMET03459 0.645 0.008 DBMET00558 0.69 0.006 DBMET02381 0.69 0.006 DBMET02382 0.657 0.007 DBMET00571 0.41 0.024 DBMET00574 0.69 0.006 DBMET02833 0.69 0.006 DBMET02834 | DBMET02834 | |
| 0.425 | 0.001 | 0.438 | 5-Alpha-reductase 2 inhibitor | 0.438 0.001 DB00624 0.117 0.005 DBMET03460 0.413 0.001 DBMET03459 0.425 0.001 DBMET00558 0.312 0.002 DBMET02381 0.312 0.002 DBMET02382 0.185 0.003 DBMET00571 0.118 0.004 DBMET00574 0.312 0.002 DBMET02833 0.312 0.002 DBMET02834 | DB00624 | |
| 0.432 | 0.01 | 0.432 | Melanin inhibitor | 0.42 0.01 DB00624 0.302 0.022 DBMET03460 0.218 0.035 DBMET03459 0.211 0.037 DBMET00558 0.183 0.049 DBMET02381 0.183 0.049 DBMET02382 0.345 0.017 DBMET00571 0.183 0.049 DBMET02833 0.183 0.049 DBMET02834 | ||
| 0.428 | 0.006 | 0.428 | Alkylator | 0.314 0.012 DB00624 0.249 0.017 DBMET03460 0.372 0.009 DBMET03459 0.251 0.016 DBMET00558 0.136 0.054 DBMET03175 0.343 0.01 DBMET02381 0.343 0.01 DBMET02382 0.404 0.007 DBMET00571 0.186 0.03 DBMET00574 0.343 0.01 DBMET02833 0.343 0.01 DBMET02834 0.135 0.056 DBMET03176 | ||
| 0.411 | 0.001 | 0.605 | RNA-directed RNA polymerase stimulant | 0.55 0.001 DB00624 0.471 0.001 DBMET03459 0.605 0.001 DBMET00558 0.587 0.001 DBMET02381 0.587 0.001 DBMET02382 0.497 0.001 DBMET00571 0.471 0.001 DBMET00574 0.587 0.001 DBMET02833 0.587 0.001 DBMET02834 | DBMET00558 | |
| 0.408 | 0.006 | 0.408 | Antipruritic | 0.352 0.009 DB00624 0.244 0.026 DBMET03460 0.289 0.016 DBMET03459 0.239 0.028 DBMET00558 0.217 0.039 DBMET02381 0.217 0.039 DBMET02382 0.135 0.115 DBMET00571 0.16 0.083 DBMET00574 0.217 0.039 DBMET02833 0.217 0.039 DBMET02834 | ||
| 0.403 | 0.011 | 0.457 | Platelet adhesion inhibitor | 0.309 0.031 DB00624 0.375 0.015 DBMET03460 0.431 0.009 DBMET03459 0.33 0.025 DBMET00558 0.404 0.011 DBMET02381 0.404 0.011 DBMET02382 0.457 0.007 DBMET00571 0.411 0.01 DBMET00574 0.404 0.011 DBMET02833 0.404 0.011 DBMET02834 0.132 0.128 DBMET03176 | DBMET00571 | |
| 0.411 | 0.02 | 0.772 | Angiogenesis stimulant | 0.375 0.026 DB00624 0.501 0.012 DBMET03460 0.4 0.022 DBMET03459 0.356 0.031 DBMET00558 0.426 0.018 DBMET02381 0.426 0.018 DBMET02382 0.772 0.004 DBMET00571 0.771 0.004 DBMET00574 0.426 0.018 DBMET02833 0.426 0.018 DBMET02834 | DBMET00571 | |
| 0.405 | 0.026 | 0.578 | Tumour necrosis factor alpha release inhibitor | 0.367 0.034 DB00624 0.481 0.016 DBMET03459 0.459 0.018 DBMET00558 0.578 0.008 DBMET03175 0.371 0.033 DBMET02381 0.371 0.033 DBMET02382 0.53 0.012 DBMET00571 0.418 0.024 DBMET00574 0.371 0.033 DBMET02833 0.371 0.033 DBMET02834 0.512 0.013 DBMET03176 | DBMET03175 | |
| 0.379 | 0.005 | 0.663 | Estrogen antagonist | 0.662 0.003 DB00624 0.119 0.058 DBMET03460 0.34 0.005 DBMET03459 0.654 0.003 DBMET00558 0.663 0.003 DBMET02381 0.663 0.003 DBMET02382 0.276 0.007 DBMET00571 0.251 0.008 DBMET00574 0.663 0.003 DBMET02833 0.663 0.003 DBMET02834 | DBMET02834 | |
| 0.382 | 0.015 | 0.694 | Hepatoprotectant | 0.396 0.014 DB00624 0.309 0.027 DBMET03460 0.476 0.008 DBMET03459 0.516 0.006 DBMET00558 0.166 0.094 DBMET03175 0.581 0.005 DBMET02381 0.581 0.005 DBMET02382 0.694 0.004 DBMET00571 0.466 0.009 DBMET00574 0.581 0.005 DBMET02833 0.581 0.005 DBMET02834 0.146 0.114 DBMET03176 | DBMET00571 | |
| 0.37 | 0.004 | 0.713 | Estrogen receptor alpha antagonist | 0.713 0.002 DB00624 0.09 0.035 DBMET03460 0.184 0.009 DBMET03459 0.475 0.004 DBMET00558 0.411 0.004 DBMET02381 0.411 0.004 DBMET02382 0.091 0.034 DBMET00574 0.411 0.004 DBMET02833 0.411 0.004 DBMET02834 | DB00624 | |
| 0.361 | 0.003 | 0.61 | Aldosterone antagonist | 0.61 0.001 DB00624 0.049 0.03 DBMET03460 0.105 0.008 DBMET03459 0.3 0.003 DBMET00558 0.29 0.003 DBMET02381 0.29 0.003 DBMET02382 0.073 0.013 DBMET00574 0.29 0.003 DBMET02833 0.29 0.003 DBMET02834 | DB00624 | |
| 0.39 | 0.037 | 0.656 | Antioxidant | 0.427 0.03 DB00624 0.354 0.045 DBMET03460 0.383 0.038 DBMET03459 0.423 0.031 DBMET00558 0.472 0.023 DBMET02381 0.472 0.023 DBMET02382 0.656 0.008 DBMET00571 0.468 0.024 DBMET00574 0.472 0.023 DBMET02833 0.472 0.023 DBMET02834 | DBMET00571 | |
| 0.35 | 0.01 | 0.432 | Gastrin inhibitor | 0.276 0.052 DB00624 0.432 0.004 DBMET03460 0.365 0.008 DBMET03459 0.293 0.038 DBMET00558 0.262 0.066 DBMET02381 0.262 0.066 DBMET02382 0.26 0.068 DBMET00571 0.19 0.164 DBMET00574 0.262 0.066 DBMET02833 0.262 0.066 DBMET02834 | DBMET03460 | |
| 0.339 | 0.001 | 0.339 | Arachidonic acid antagonist | 0.329 0.001 DB00624 0.269 0.003 DBMET03460 0.326 0.001 DBMET03459 0.317 0.001 DBMET00558 0.291 0.002 DBMET02381 0.291 0.002 DBMET02382 0.264 0.004 DBMET00571 0.272 0.003 DBMET00574 0.291 0.002 DBMET02833 0.291 0.002 DBMET02834 | ||
| 0.349 | 0.012 | 0.423 | Protein kinase stimulant | 0.202 0.041 DB00624 0.423 0.007 DBMET03460 0.304 0.016 DBMET03459 0.174 0.053 DBMET00558 0.234 0.031 DBMET02381 0.234 0.031 DBMET02382 0.268 0.022 DBMET00571 0.234 0.031 DBMET02833 0.234 0.031 DBMET02834 | DBMET03460 | |
| 0.408 | 0.073 | 0.69 | Antibacterial | 0.325 0.117 DB00624 0.4 0.077 DBMET03460 0.492 0.043 DBMET03459 0.422 0.067 DBMET00558 0.479 0.047 DBMET03175 0.386 0.083 DBMET02381 0.386 0.083 DBMET02382 0.69 0.009 DBMET00571 0.496 0.042 DBMET00574 0.386 0.083 DBMET02833 0.386 0.083 DBMET02834 0.416 0.07 DBMET03176 | DBMET00571 | |
| 0.358 | 0.029 | 0.846 | DNA synthesis inhibitor | 0.344 0.031 DB00624 0.424 0.019 DBMET03460 0.354 0.029 DBMET03459 0.34 0.033 DBMET00558 0.846 0.003 DBMET03175 0.383 0.024 DBMET02381 0.383 0.024 DBMET02382 0.484 0.015 DBMET00571 0.213 0.104 DBMET00574 0.383 0.024 DBMET02833 0.383 0.024 DBMET02834 0.842 0.003 DBMET03176 | DBMET03175 | |
| 0.361 | 0.033 | 0.551 | Hypolipemic | 0.26 0.063 DB00624 0.551 0.009 DBMET03460 0.415 0.023 DBMET03459 0.329 0.041 DBMET00558 0.52 0.011 DBMET02381 0.52 0.011 DBMET02382 0.346 0.036 DBMET00571 0.52 0.011 DBMET02833 0.52 0.011 DBMET02834 | DBMET03460 | |
| 0.331 | 0.004 | 0.579 | Pregnane X receptor agonist | 0.519 0.002 DB00624 0.166 0.03 DBMET03460 0.373 0.003 DBMET03459 0.579 0.002 DBMET00558 0.533 0.002 DBMET02381 0.533 0.002 DBMET02382 0.146 0.06 DBMET00571 0.439 0.003 DBMET00574 0.533 0.002 DBMET02833 0.533 0.002 DBMET02834 | DBMET00558 | |
| 0.329 | 0.003 | 0.551 | Progesterone antagonist | 0.551 0.002 DB00624 0.22 0.004 DBMET03459 0.393 0.003 DBMET00558 0.291 0.004 DBMET02381 0.291 0.004 DBMET02382 0.044 0.02 DBMET00574 0.291 0.004 DBMET02833 0.291 0.004 DBMET02834 | DB00624 | |
| 0.318 | 0.005 | 0.484 | Farnesoid X receptor antagonist | 0.376 0.004 DB00624 0.217 0.017 DBMET03460 0.342 0.004 DBMET03459 0.408 0.004 DBMET00558 0.484 0.003 DBMET02381 0.484 0.003 DBMET02382 0.229 0.015 DBMET00571 0.292 0.006 DBMET00574 0.484 0.003 DBMET02833 0.484 0.003 DBMET02834 | DBMET02834 | |
| 0.325 | 0.017 | 0.551 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.377 0.009 DB00624 0.349 0.013 DBMET03460 0.283 0.029 DBMET03459 0.336 0.015 DBMET00558 0.551 0.003 DBMET03175 0.265 0.036 DBMET02381 0.265 0.036 DBMET02382 0.212 0.063 DBMET00571 0.265 0.036 DBMET02833 0.265 0.036 DBMET02834 0.547 0.003 DBMET03176 | DBMET03175 | |
| 0.307 | 0.002 | 0.396 | Glycine receptor antagonist | 0.262 0.002 DB00624 0.196 0.004 DBMET03460 0.276 0.002 DBMET03459 0.236 0.003 DBMET00558 0.276 0.002 DBMET02381 0.276 0.002 DBMET02382 0.264 0.002 DBMET00571 0.396 0.001 DBMET00574 0.276 0.002 DBMET02833 0.276 0.002 DBMET02834 | DBMET00574 | |
| 0.357 | 0.055 | 0.662 | 5 Hydroxytryptamine release stimulant | 0.324 0.063 DB00624 0.662 0.009 DBMET03460 0.414 0.043 DBMET03459 0.381 0.05 DBMET00558 0.459 0.034 DBMET02381 0.459 0.034 DBMET02382 0.418 0.042 DBMET00571 0.459 0.034 DBMET02833 0.459 0.034 DBMET02834 | DBMET03460 | |
| 0.305 | 0.003 | 0.47 | Bile acid receptor antagonist | 0.35 0.003 DB00624 0.166 0.005 DBMET03460 0.301 0.003 DBMET03459 0.345 0.003 DBMET00558 0.47 0.002 DBMET02381 0.47 0.002 DBMET02382 0.147 0.008 DBMET00571 0.291 0.003 DBMET00574 0.47 0.002 DBMET02833 0.47 0.002 DBMET02834 | DBMET02834 | |
| 0.313 | 0.012 | 0.679 | Adenylate cyclase inhibitor | 0.451 0.006 DB00624 0.201 0.025 DBMET03460 0.2 0.025 DBMET03459 0.329 0.011 DBMET00558 0.679 0.002 DBMET03175 0.313 0.012 DBMET02381 0.313 0.012 DBMET02382 0.177 0.031 DBMET00571 0.313 0.012 DBMET02833 0.313 0.012 DBMET02834 0.675 0.002 DBMET03176 | DBMET03175 | |
| 0.312 | 0.015 | 0.553 | Neurotrophic factor enhancer | 0.338 0.011 DB00624 0.311 0.015 DBMET03460 0.513 0.004 DBMET03459 0.553 0.003 DBMET00558 0.498 0.004 DBMET02381 0.498 0.004 DBMET02382 0.512 0.004 DBMET00571 0.238 0.045 DBMET00574 0.498 0.004 DBMET02833 0.498 0.004 DBMET02834 | DBMET00558 | |
| 0.298 | 0.012 | 0.56 | Aldehyde dehydrogenase inhibitor | 0.357 0.007 DB00624 0.557 0.004 DBMET03460 0.159 0.042 DBMET03459 0.203 0.027 DBMET00558 0.531 0.004 DBMET03175 0.236 0.02 DBMET02381 0.236 0.02 DBMET02382 0.136 0.057 DBMET00571 0.236 0.02 DBMET02833 0.236 0.02 DBMET02834 0.56 0.004 DBMET03176 | DBMET03176 | |
| 0.298 | 0.015 | 0.335 | Interleukin 6 antagonist | 0.26 0.021 DB00624 0.257 0.022 DBMET03460 0.333 0.011 DBMET03459 0.302 0.014 DBMET00558 0.156 0.08 DBMET03175 0.32 0.012 DBMET02381 0.32 0.012 DBMET02382 0.335 0.011 DBMET00571 0.32 0.012 DBMET02833 0.32 0.012 DBMET02834 | DBMET00571 | |
| 0.353 | 0.072 | 0.671 | Vasodilator, peripheral | 0.288 0.103 DB00624 0.671 0.008 DBMET03460 0.334 0.081 DBMET03459 0.269 0.114 DBMET00558 0.296 0.099 DBMET03175 0.354 0.072 DBMET02381 0.354 0.072 DBMET02382 0.205 0.17 DBMET00571 0.354 0.072 DBMET02833 0.354 0.072 DBMET02834 0.316 0.089 DBMET03176 | DBMET03460 | |
| 0.334 | 0.058 | 0.434 | Spasmolytic | 0.394 0.041 DBMET03460 0.434 0.034 DBMET03459 0.208 0.113 DBMET00558 0.223 0.104 DBMET02381 0.223 0.104 DBMET02382 0.256 0.089 DBMET00571 0.223 0.104 DBMET02833 0.223 0.104 DBMET02834 | DBMET03459 | |
| 0.293 | 0.02 | 0.355 | Lipid peroxidase inhibitor | 0.306 0.018 DB00624 0.268 0.024 DBMET03460 0.213 0.037 DBMET03459 0.21 0.037 DBMET00558 0.231 0.031 DBMET02381 0.231 0.031 DBMET02382 0.355 0.012 DBMET00571 0.131 0.083 DBMET00574 0.231 0.031 DBMET02833 0.231 0.031 DBMET02834 | DBMET00571 | |
| 0.285 | 0.013 | 0.514 | DNA polymerase I inhibitor | 0.294 0.012 DB00624 0.39 0.006 DBMET03460 0.266 0.015 DBMET03459 0.272 0.014 DBMET00558 0.513 0.004 DBMET03175 0.308 0.011 DBMET02381 0.308 0.011 DBMET02382 0.242 0.018 DBMET00571 0.172 0.038 DBMET00574 0.308 0.011 DBMET02833 0.308 0.011 DBMET02834 0.514 0.004 DBMET03176 | DBMET03176 | |
| 0.29 | 0.018 | 0.362 | Bone formation stimulant | 0.258 0.023 DB00624 0.362 0.012 DBMET03460 0.286 0.019 DBMET03459 0.249 0.025 DBMET00558 0.253 0.024 DBMET02381 0.253 0.024 DBMET02382 0.159 0.052 DBMET00571 0.253 0.024 DBMET02833 0.253 0.024 DBMET02834 | DBMET03460 | |
| 0.339 | 0.069 | 0.666 | Antithrombotic | 0.266 0.114 DB00624 0.611 0.015 DBMET03460 0.342 0.067 DBMET03459 0.269 0.111 DBMET00558 0.666 0.01 DBMET03175 0.322 0.076 DBMET02381 0.322 0.076 DBMET02382 0.621 0.014 DBMET00571 0.472 0.033 DBMET00574 0.322 0.076 DBMET02833 0.322 0.076 DBMET02834 0.633 0.013 DBMET03176 | DBMET03175 | |
| 0.265 | 0.004 | 0.539 | Estrogen receptor alpha agonist | 0.516 0.002 DB00624 0.227 0.004 DBMET03459 0.502 0.002 DBMET00558 0.539 0.002 DBMET02381 0.539 0.002 DBMET02382 0.137 0.005 DBMET00571 0.22 0.004 DBMET00574 0.539 0.002 DBMET02833 0.539 0.002 DBMET02834 | DBMET02834 | |
| 0.326 | 0.068 | 0.561 | Caspase 3 stimulant | 0.432 0.035 DB00624 0.271 0.095 DBMET03460 0.36 0.056 DBMET03459 0.467 0.026 DBMET00558 0.561 0.013 DBMET02381 0.561 0.013 DBMET02382 0.437 0.033 DBMET00571 0.561 0.013 DBMET02833 0.561 0.013 DBMET02834 | DBMET02834 | |
| 0.26 | 0.006 | 0.268 | Microtubule formation inhibitor | 0.26 0.006 DB00624 0.185 0.024 DBMET03460 0.268 0.005 DBMET03459 0.267 0.005 DBMET00558 0.268 0.005 DBMET02381 0.268 0.005 DBMET02382 0.266 0.005 DBMET00571 0.135 0.047 DBMET00574 0.268 0.005 DBMET02833 0.268 0.005 DBMET02834 | DBMET02834 | |
| 0.251 | 0.003 | 0.267 | Glycine receptor agonist | 0.264 0.003 DB00624 0.262 0.003 DBMET03460 0.179 0.005 DBMET03459 0.194 0.004 DBMET00558 0.267 0.003 DBMET02381 0.267 0.003 DBMET02382 0.178 0.005 DBMET00571 0.096 0.023 DBMET00574 0.267 0.003 DBMET02833 0.267 0.003 DBMET02834 | DBMET02834 | |
| 0.251 | 0.004 | 0.584 | Estradiol 17 beta-dehydrogenase inhibitor | 0.584 0.002 DB00624 0.212 0.004 DBMET03459 0.533 0.002 DBMET00558 0.443 0.002 DBMET02381 0.443 0.002 DBMET02382 0.04 0.031 DBMET00571 0.122 0.008 DBMET00574 0.443 0.002 DBMET02833 0.443 0.002 DBMET02834 | DB00624 | |
| 0.289 | 0.051 | 0.607 | 5 Hydroxytryptamine uptake stimulant | 0.245 0.086 DB00624 0.607 0.003 DBMET03460 0.277 0.058 DBMET03459 0.235 0.096 DBMET00558 0.255 0.076 DBMET02381 0.255 0.076 DBMET02382 0.255 0.076 DBMET02833 0.255 0.076 DBMET02834 | DBMET03460 | |
| 0.243 | 0.007 | 0.508 | Estrogen receptor beta antagonist | 0.503 0.004 DB00624 0.091 0.082 DBMET03460 0.22 0.008 DBMET03459 0.508 0.004 DBMET00558 0.475 0.004 DBMET02381 0.475 0.004 DBMET02382 0.129 0.024 DBMET00571 0.176 0.012 DBMET00574 0.475 0.004 DBMET02833 0.475 0.004 DBMET02834 | DBMET00558 | |
| 0.232 | 0.005 | 0.284 | Adenylate cyclase stimulant | 0.253 0.004 DB00624 0.273 0.003 DBMET03460 0.239 0.005 DBMET03459 0.261 0.004 DBMET00558 0.152 0.059 DBMET03175 0.284 0.003 DBMET02381 0.284 0.003 DBMET02382 0.176 0.029 DBMET00571 0.235 0.005 DBMET00574 0.284 0.003 DBMET02833 0.284 0.003 DBMET02834 0.152 0.06 DBMET03176 | DBMET02834 | |
| 0.231 | 0.004 | 0.523 | Estrogen receptor beta agonist | 0.517 0.003 DB00624 0.212 0.004 DBMET03459 0.523 0.003 DBMET00558 0.522 0.003 DBMET02381 0.522 0.003 DBMET02382 0.218 0.004 DBMET00571 0.365 0.003 DBMET00574 0.522 0.003 DBMET02833 0.522 0.003 DBMET02834 | DBMET00558 | |
| 0.272 | 0.052 | 0.378 | Antimitotic | 0.344 0.034 DB00624 0.297 0.044 DBMET03459 0.378 0.027 DBMET00558 0.342 0.034 DBMET02381 0.342 0.034 DBMET02382 0.234 0.066 DBMET00574 0.342 0.034 DBMET02833 0.342 0.034 DBMET02834 | DBMET00558 | |
| 0.251 | 0.043 | 0.519 | Growth hormone agonist | 0.277 0.037 DB00624 0.519 0.005 DBMET03460 0.257 0.042 DBMET03459 0.287 0.035 DBMET00558 0.306 0.031 DBMET02381 0.306 0.031 DBMET02382 0.306 0.031 DBMET02833 0.306 0.031 DBMET02834 | DBMET03460 | |
| 0.239 | 0.031 | 0.359 | Amylase inhibitor | 0.359 0.012 DB00624 0.296 0.019 DBMET03460 0.193 0.047 DBMET00558 0.259 0.026 DBMET02381 0.259 0.026 DBMET02382 0.349 0.013 DBMET00571 0.259 0.026 DBMET02833 0.259 0.026 DBMET02834 | DB00624 | |
| 0.21 | 0.003 | 0.324 | Glucocorticoid antagonist | 0.324 0.002 DB00624 0.111 0.005 DBMET03459 0.213 0.003 DBMET00558 0.205 0.003 DBMET02381 0.205 0.003 DBMET02382 0.084 0.006 DBMET00571 0.102 0.005 DBMET00574 0.205 0.003 DBMET02833 0.205 0.003 DBMET02834 | DB00624 | |
| 0.231 | 0.027 | 0.285 | Monophenol monooxygenase inhibitor | 0.203 0.033 DB00624 0.249 0.024 DBMET03460 0.125 0.058 DBMET03459 0.108 0.07 DBMET00558 0.285 0.019 DBMET00571 | DBMET00571 | |
| 0.206 | 0.004 | 0.395 | Mineralocorticoid receptor antagonist | 0.395 0.003 DB00624 0.101 0.008 DBMET03459 0.209 0.004 DBMET00558 0.148 0.005 DBMET02381 0.148 0.005 DBMET02382 0.056 0.023 DBMET00571 0.083 0.01 DBMET00574 0.148 0.005 DBMET02833 0.148 0.005 DBMET02834 | DB00624 | |
| 0.203 | 0.006 | 0.203 | Toll-Like receptor 4 antagonist | 0.146 0.023 DB00624 0.191 0.008 DBMET03460 0.187 0.008 DBMET03459 0.095 0.078 DBMET00558 0.168 0.013 DBMET03175 0.103 0.064 DBMET02381 0.103 0.064 DBMET02382 0.159 0.016 DBMET00571 0.103 0.064 DBMET02833 0.103 0.064 DBMET02834 0.169 0.013 DBMET03176 | ||
| 0.222 | 0.027 | 0.253 | Anesthetic local | 0.134 0.057 DB00624 0.181 0.037 DBMET03460 0.253 0.019 DBMET03459 0.164 0.043 DBMET00558 0.213 0.029 DBMET02381 0.213 0.029 DBMET02382 0.213 0.029 DBMET02833 0.213 0.029 DBMET02834 | DBMET03459 | |
| 0.203 | 0.01 | 0.291 | AMP-activated protein kinase stimulant | 0.291 0.005 DB00624 0.151 0.028 DBMET03460 0.112 0.056 DBMET03459 0.152 0.027 DBMET00558 0.221 0.009 DBMET02381 0.221 0.009 DBMET02382 0.289 0.005 DBMET00571 0.221 0.009 DBMET02833 0.221 0.009 DBMET02834 | DB00624 | |
| 0.204 | 0.012 | 0.214 | Acetylcholine nicotinic antagonist | 0.134 0.025 DB00624 0.081 0.053 DBMET03460 0.212 0.012 DBMET03459 0.138 0.024 DBMET00558 0.214 0.012 DBMET02381 0.214 0.012 DBMET02382 0.214 0.012 DBMET02833 0.214 0.012 DBMET02834 | DBMET02834 | |
| 0.254 | 0.067 | 0.478 | Free radical scavenger | 0.26 0.064 DB00624 0.294 0.053 DBMET03460 0.2 0.098 DBMET03459 0.194 0.102 DBMET00558 0.207 0.092 DBMET02381 0.207 0.092 DBMET02382 0.478 0.018 DBMET00571 0.207 0.092 DBMET02833 0.207 0.092 DBMET02834 | DBMET00571 | |
| 0.197 | 0.009 | 0.309 | Prolactin inhibitor | 0.14 0.027 DB00624 0.309 0.003 DBMET03460 0.236 0.005 DBMET03459 0.176 0.014 DBMET00558 0.218 0.006 DBMET02381 0.218 0.006 DBMET02382 0.218 0.006 DBMET02833 0.218 0.006 DBMET02834 | DBMET03460 | |
| 0.279 | 0.094 | 0.76 | Immunomodulator | 0.205 0.158 DB00624 0.536 0.018 DBMET03460 0.208 0.154 DBMET03459 0.76 0.005 DBMET03175 0.24 0.123 DBMET02381 0.24 0.123 DBMET02382 0.367 0.054 DBMET00571 0.24 0.123 DBMET02833 0.24 0.123 DBMET02834 0.713 0.005 DBMET03176 | DBMET03175 | |
| 0.177 | 0.003 | 0.365 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.365 0.002 DB00624 0.11 0.004 DBMET03459 0.238 0.003 DBMET00558 0.228 0.003 DBMET02381 0.228 0.003 DBMET02382 0.187 0.003 DBMET00571 0.037 0.012 DBMET00574 0.228 0.003 DBMET02833 0.228 0.003 DBMET02834 | DB00624 | |
| 0.18 | 0.007 | 0.238 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DB00624 0.238 0.002 DBMET03460 0.186 0.005 DBMET03459 0.159 0.026 DBMET00558 0.166 0.016 DBMET02381 0.166 0.016 DBMET02382 0.156 0.031 DBMET00571 0.166 0.016 DBMET02833 0.166 0.016 DBMET02834 | DBMET03460 | |
| 0.192 | 0.022 | 0.317 | Cyclooxygenase 3 inhibitor | 0.152 0.047 DB00624 0.225 0.012 DBMET03460 0.207 0.016 DBMET03459 0.166 0.036 DBMET00558 0.153 0.046 DBMET02381 0.153 0.046 DBMET02382 0.317 0.005 DBMET00571 0.153 0.046 DBMET02833 0.153 0.046 DBMET02834 | DBMET00571 | |
| 0.171 | 0.003 | 0.498 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.498 0.002 DB00624 0.119 0.004 DBMET03459 0.378 0.002 DBMET00558 0.414 0.002 DBMET02381 0.414 0.002 DBMET02382 0.064 0.007 DBMET00574 0.414 0.002 DBMET02833 0.414 0.002 DBMET02834 | DB00624 | |
| 0.165 | 0.003 | 0.202 | Progesterone agonist | 0.202 0.002 DB00624 0.119 0.003 DBMET03459 0.157 0.003 DBMET00558 0.132 0.003 DBMET02381 0.132 0.003 DBMET02382 0.048 0.005 DBMET00571 0.071 0.004 DBMET00574 0.132 0.003 DBMET02833 0.132 0.003 DBMET02834 | DB00624 | |
| 0.163 | 0.004 | 0.309 | Na+ K+ transporting ATPase inhibitor | 0.2 0.002 DB00624 0.116 0.019 DBMET03460 0.18 0.003 DBMET03459 0.236 0.002 DBMET00558 0.225 0.002 DBMET02381 0.225 0.002 DBMET02382 0.309 0.001 DBMET00571 0.217 0.002 DBMET00574 0.225 0.002 DBMET02833 0.225 0.002 DBMET02834 | DBMET00571 | |
| 0.175 | 0.021 | 0.226 | Interleukin 8 antagonist | 0.226 0.008 DB00624 0.196 0.014 DBMET03460 0.121 0.061 DBMET00558 | DB00624 | |
| 0.149 | 0.003 | 0.229 | Estrone sulfatase inhibitor | 0.166 0.003 DB00624 0.144 0.004 DBMET03459 0.163 0.003 DBMET00558 0.161 0.003 DBMET02381 0.161 0.003 DBMET02382 0.046 0.008 DBMET00571 0.229 0.002 DBMET00574 0.161 0.003 DBMET02833 0.161 0.003 DBMET02834 | DBMET00574 | |
| 0.146 | 0.005 | 0.376 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.376 0.002 DB00624 0.058 0.032 DBMET03460 0.067 0.024 DBMET03459 0.254 0.003 DBMET00558 0.237 0.003 DBMET02381 0.237 0.003 DBMET02382 0.126 0.007 DBMET00574 0.237 0.003 DBMET02833 0.237 0.003 DBMET02834 | DB00624 | |
| 0.202 | 0.061 | 0.473 | Growth factor agonist | 0.291 0.017 DB00624 0.309 0.013 DBMET03459 0.473 0.005 DBMET00558 0.362 0.007 DBMET02381 0.362 0.007 DBMET02382 0.284 0.019 DBMET00571 0.199 0.064 DBMET00574 0.362 0.007 DBMET02833 0.362 0.007 DBMET02834 | DBMET00558 | |
| 0.217 | 0.077 | 0.623 | RNA-directed DNA polymerase inhibitor | 0.26 0.044 DB00624 0.369 0.022 DBMET03460 0.259 0.044 DBMET03459 0.332 0.026 DBMET00558 0.623 0.004 DBMET03175 0.294 0.033 DBMET02381 0.294 0.033 DBMET02382 0.308 0.03 DBMET00571 0.488 0.012 DBMET00574 0.294 0.033 DBMET02833 0.294 0.033 DBMET02834 0.623 0.004 DBMET03176 | DBMET03176 | |
| 0.149 | 0.011 | 0.251 | Ornithine decarboxylase inhibitor | 0.126 0.022 DB00624 0.251 0.004 DBMET03460 0.146 0.012 DBMET03459 0.124 0.023 DBMET00558 0.107 0.037 DBMET02381 0.107 0.037 DBMET02382 0.097 0.048 DBMET00571 0.107 0.037 DBMET02833 0.107 0.037 DBMET02834 | DBMET03460 | |
| 0.135 | 0.002 | 0.144 | Lipocortins synthesis agonist | 0.144 0.002 DB00624 0.08 0.013 DBMET03460 0.125 0.003 DBMET03459 0.132 0.002 DBMET00558 0.128 0.003 DBMET02381 0.128 0.003 DBMET02382 0.114 0.004 DBMET00571 0.111 0.004 DBMET00574 0.128 0.003 DBMET02833 0.128 0.003 DBMET02834 | DB00624 | |
| 0.177 | 0.046 | 0.263 | Tubulin antagonist | 0.263 0.024 DB00624 0.162 0.053 DBMET03459 0.249 0.025 DBMET00558 0.198 0.037 DBMET02381 0.198 0.037 DBMET02382 0.162 0.053 DBMET00574 0.198 0.037 DBMET02833 0.198 0.037 DBMET02834 | DB00624 | |
| 0.152 | 0.023 | 0.267 | Hedgehog signaling inhibitor | 0.267 0.005 DB00624 0.135 0.03 DBMET00558 0.234 0.008 DBMET02381 0.234 0.008 DBMET02382 0.105 0.056 DBMET00571 0.234 0.008 DBMET02833 0.234 0.008 DBMET02834 | DB00624 | |
| 0.294 | 0.168 | 0.746 | Cyclophilin D inhibitor | 0.39 0.096 DB00624 0.649 0.02 DBMET03460 0.327 0.14 DBMET03459 0.438 0.072 DBMET00558 0.57 0.033 DBMET02381 0.57 0.033 DBMET02382 0.746 0.01 DBMET00571 0.295 0.167 DBMET00574 0.57 0.033 DBMET02833 0.57 0.033 DBMET02834 | DBMET00571 | |
| 0.137 | 0.014 | 0.317 | Beta tubulin antagonist | 0.298 0.005 DB00624 0.133 0.015 DBMET03459 0.317 0.005 DBMET00558 0.298 0.005 DBMET02381 0.298 0.005 DBMET02382 0.143 0.013 DBMET00574 0.298 0.005 DBMET02833 0.298 0.005 DBMET02834 | DBMET00558 | |
| 0.124 | 0.003 | 0.126 | Pregnane X receptor antagonist | 0.126 0.002 DB00624 0.098 0.004 DBMET03460 0.093 0.004 DBMET03459 0.094 0.004 DBMET00558 0.091 0.004 DBMET02381 0.091 0.004 DBMET02382 0.091 0.004 DBMET02833 0.091 0.004 DBMET02834 | DB00624 | |
| 0.148 | 0.028 | 0.218 | Antineoplastic alkaloid | 0.126 0.035 DB00624 0.112 0.041 DBMET03460 0.217 0.009 DBMET03459 0.218 0.009 DBMET00558 0.197 0.014 DBMET02381 0.197 0.014 DBMET02382 0.096 0.05 DBMET00571 0.197 0.014 DBMET02833 0.197 0.014 DBMET02834 | DBMET00558 | |
| 0.15 | 0.031 | 0.403 | Photosensitizer | 0.403 0.003 DBMET03460 0.137 0.04 DBMET03459 0.114 0.065 DBMET00571 | DBMET03460 | |
| 0.216 | 0.099 | 0.616 | Hypoglycemic | 0.205 0.107 DB00624 0.529 0.013 DBMET03460 0.256 0.073 DBMET03459 0.252 0.075 DBMET00558 0.286 0.058 DBMET02381 0.286 0.058 DBMET02382 0.616 0.007 DBMET00571 0.286 0.058 DBMET02833 0.286 0.058 DBMET02834 | DBMET00571 | |
| 0.138 | 0.021 | 0.163 | ABCA1 expression enhancer | 0.157 0.016 DB00624 0.163 0.014 DBMET03460 0.096 0.055 DBMET03459 0.102 0.047 DBMET00558 0.163 0.014 DBMET02381 0.163 0.014 DBMET02382 0.163 0.014 DBMET02833 0.163 0.014 DBMET02834 | DBMET02834 | |
| 0.119 | 0.01 | 0.17 | Estrogen-related receptor beta agonist | 0.17 0.003 DB00624 0.137 0.005 DBMET03460 0.109 0.016 DBMET03459 0.153 0.004 DBMET00558 0.17 0.003 DBMET02381 0.17 0.003 DBMET02382 0.17 0.003 DBMET02833 0.17 0.003 DBMET02834 | DBMET02834 | |
| 0.126 | 0.019 | 0.256 | Keratolytic | 0.256 0.005 DB00624 0.215 0.007 DBMET03460 0.102 0.029 DBMET03459 0.213 0.007 DBMET00558 0.252 0.005 DBMET02381 0.252 0.005 DBMET02382 0.252 0.005 DBMET02833 0.252 0.005 DBMET02834 | DB00624 | |
| 0.155 | 0.05 | 0.184 | Cholinergic antagonist | 0.117 0.076 DB00624 0.1 0.096 DBMET03460 0.165 0.045 DBMET03459 0.125 0.069 DBMET00558 0.184 0.037 DBMET02381 0.184 0.037 DBMET02382 0.184 0.037 DBMET02833 0.184 0.037 DBMET02834 | DBMET02834 | |
| 0.127 | 0.026 | 0.228 | Thioredoxin inhibitor | 0.228 0.006 DBMET03460 0.154 0.015 DBMET03459 0.097 0.052 DBMET00571 | DBMET03460 | |
| 0.154 | 0.056 | 0.3 | Neurotrophic factor | 0.175 0.041 DB00624 0.194 0.03 DBMET03460 0.176 0.04 DBMET03459 0.203 0.026 DBMET00558 0.3 0.008 DBMET02381 0.3 0.008 DBMET02382 0.14 0.068 DBMET00571 0.3 0.008 DBMET02833 0.3 0.008 DBMET02834 | DBMET02834 | |
| 0.149 | 0.051 | 0.181 | Acetylcholine antagonist | 0.115 0.075 DB00624 0.159 0.045 DBMET03459 0.123 0.068 DBMET00558 0.181 0.036 DBMET02381 0.181 0.036 DBMET02382 0.181 0.036 DBMET02833 0.181 0.036 DBMET02834 | DBMET02834 | |
| 0.162 | 0.064 | 0.385 | Phospholipase A2 inhibitor | 0.385 0.005 DBMET03460 0.138 0.089 DBMET03459 | DBMET03460 | |
| 0.118 | 0.025 | 0.126 | Inducible nitric-oxide synthase inhibitor | 0.126 0.022 DB00624 0.117 0.026 DBMET03460 0.084 0.056 DBMET03459 0.088 0.05 DBMET00558 0.084 0.055 DBMET02381 0.084 0.055 DBMET02382 0.078 0.066 DBMET00574 0.084 0.055 DBMET02833 0.084 0.055 DBMET02834 | DB00624 | |
| 0.113 | 0.021 | 0.259 | CDC25A inhibitor | 0.116 0.02 DB00624 0.207 0.006 DBMET03460 0.161 0.011 DBMET03459 0.176 0.009 DBMET00558 0.201 0.007 DBMET02381 0.201 0.007 DBMET02382 0.087 0.036 DBMET00571 0.259 0.004 DBMET00574 0.201 0.007 DBMET02833 0.201 0.007 DBMET02834 | DBMET00574 | |
| 0.203 | 0.116 | 0.61 | Cardiotonic | 0.294 0.059 DB00624 0.179 0.141 DBMET03460 0.319 0.049 DBMET03459 0.444 0.022 DBMET00558 0.259 0.076 DBMET03175 0.61 0.007 DBMET02381 0.61 0.007 DBMET02382 0.195 0.123 DBMET00571 0.61 0.007 DBMET02833 0.61 0.007 DBMET02834 | DBMET02834 | |
| 0.097 | 0.01 | 0.097 | Nitric oxide donor | 0.071 0.032 DB00624 0.087 0.016 DBMET03460 0.089 0.015 DBMET03459 0.072 0.031 DBMET02381 0.072 0.031 DBMET02382 0.068 0.035 DBMET00571 0.072 0.031 DBMET02833 0.072 0.031 DBMET02834 | ||
| 0.093 | 0.009 | 0.148 | Potassium channel Kv1.3 blocker | 0.093 0.009 DB00624 0.048 0.032 DBMET03460 0.148 0.004 DBMET03459 0.147 0.004 DBMET00558 0.107 0.007 DBMET02381 0.107 0.007 DBMET02382 0.107 0.007 DBMET02833 0.107 0.007 DBMET02834 | DBMET03459 | |
| 0.154 | 0.071 | 0.45 | Insulin secretagoues | 0.45 0.005 DBMET03460 0.157 0.068 DBMET03459 0.207 0.032 DBMET02381 0.207 0.032 DBMET02382 0.264 0.017 DBMET00571 0.207 0.032 DBMET02833 0.207 0.032 DBMET02834 | DBMET03460 | |
| 0.179 | 0.096 | 0.381 | Insulin sensitizer | 0.381 0.007 DBMET03460 0.197 0.076 DBMET03459 0.163 0.116 DBMET02381 0.163 0.116 DBMET02382 0.163 0.116 DBMET02833 0.163 0.116 DBMET02834 | DBMET03460 | |
| 0.097 | 0.015 | 0.291 | Alpha tubulin antagonist | 0.243 0.005 DB00624 0.112 0.014 DBMET03459 0.286 0.004 DBMET00558 0.291 0.004 DBMET02381 0.291 0.004 DBMET02382 0.169 0.008 DBMET00574 0.291 0.004 DBMET02833 0.291 0.004 DBMET02834 | DBMET02834 | |
| 0.192 | 0.111 | 0.501 | Vasodilator | 0.424 0.019 DBMET03460 0.224 0.087 DBMET03459 0.153 0.152 DBMET00558 0.501 0.012 DBMET03175 0.239 0.076 DBMET02381 0.239 0.076 DBMET02382 0.294 0.05 DBMET00571 0.239 0.076 DBMET02833 0.239 0.076 DBMET02834 0.367 0.029 DBMET03176 | DBMET03175 | |
| 0.124 | 0.043 | 0.149 | Acetylcholine release stimulant | 0.106 0.073 DB00624 0.149 0.017 DBMET03460 0.1 0.086 DBMET00571 0.148 0.018 DBMET00574 | DBMET03460 | |
| 0.12 | 0.039 | 0.29 | Antineoplastic antibiotic | 0.144 0.032 DB00624 0.141 0.033 DBMET03459 0.174 0.026 DBMET00558 0.176 0.025 DBMET02381 0.176 0.025 DBMET02382 0.29 0.01 DBMET00571 0.13 0.036 DBMET00574 0.176 0.025 DBMET02833 0.176 0.025 DBMET02834 | DBMET00571 | |
| 0.136 | 0.055 | 0.262 | Vanilloid 1 agonist | 0.262 0.005 DBMET03460 0.136 0.056 DBMET03459 | DBMET03460 | |
| 0.082 | 0.004 | 0.622 | Glucose-6-phosphate dehydrogenase inhibitor | 0.113 0.003 DB00624 0.115 0.003 DBMET03459 0.203 0.002 DBMET00558 0.622 0.001 DBMET02381 0.622 0.001 DBMET02382 0.088 0.003 DBMET00571 0.116 0.003 DBMET00574 0.622 0.001 DBMET02833 0.622 0.001 DBMET02834 | DBMET02834 | |
| 0.08 | 0.002 | 0.097 | Corticosteroid-like | 0.097 0.002 DB00624 0.019 0.018 DBMET03460 0.044 0.004 DBMET03459 0.05 0.003 DBMET00558 0.051 0.003 DBMET02381 0.051 0.003 DBMET02382 0.04 0.004 DBMET00571 0.031 0.006 DBMET00574 0.051 0.003 DBMET02833 0.051 0.003 DBMET02834 | DB00624 | |
| 0.078 | 0.003 | 0.124 | Glucocorticoid agonist | 0.124 0.002 DB00624 0.049 0.005 DBMET03459 0.062 0.004 DBMET00558 0.063 0.004 DBMET02381 0.063 0.004 DBMET02382 0.018 0.008 DBMET00571 0.038 0.005 DBMET00574 0.063 0.004 DBMET02833 0.063 0.004 DBMET02834 | DB00624 | |
| 0.128 | 0.057 | 0.254 | Protein-tyrosine phosphatase 1B inhibitor | 0.122 0.062 DB00624 0.254 0.016 DBMET03460 0.179 0.035 DBMET03459 0.183 0.034 DBMET00558 0.195 0.031 DBMET02381 0.195 0.031 DBMET02382 0.182 0.034 DBMET00571 0.227 0.022 DBMET00574 0.195 0.031 DBMET02833 0.195 0.031 DBMET02834 | DBMET03460 | |
| 0.08 | 0.015 | 0.1 | Heme oxygenase stimulant | 0.1 0.007 DB00624 0.074 0.02 DBMET03459 0.096 0.008 DBMET00558 0.098 0.008 DBMET02381 0.098 0.008 DBMET02382 0.073 0.022 DBMET00571 0.073 0.021 DBMET00574 0.098 0.008 DBMET02833 0.098 0.008 DBMET02834 | DB00624 | |
| 0.101 | 0.038 | 0.197 | Transcription factor NF kappa B stimulant | 0.117 0.027 DB00624 0.152 0.015 DBMET03460 0.119 0.026 DBMET03459 0.143 0.018 DBMET00558 0.144 0.017 DBMET03175 0.172 0.012 DBMET02381 0.172 0.012 DBMET02382 0.197 0.009 DBMET00571 0.172 0.012 DBMET02833 0.172 0.012 DBMET02834 0.144 0.017 DBMET03176 | DBMET00571 | |
| 0.066 | 0.002 | 0.122 | Hedgehog signaling activator | 0.066 0.002 DB00624 0.042 0.004 DBMET03460 0.064 0.002 DBMET03459 0.065 0.002 DBMET00558 0.122 0.001 DBMET02381 0.122 0.001 DBMET02382 0.029 0.015 DBMET00574 0.122 0.001 DBMET02833 0.122 0.001 DBMET02834 | DBMET02834 | |
| 0.107 | 0.045 | 0.191 | Lanosterol 14 alpha demethylase inhibitor | 0.113 0.038 DB00624 0.179 0.005 DBMET03460 0.11 0.042 DBMET03459 0.116 0.035 DBMET00558 0.191 0.005 DBMET02381 0.191 0.005 DBMET02382 0.191 0.005 DBMET02833 0.191 0.005 DBMET02834 | DBMET02834 | |
| 0.075 | 0.014 | 0.117 | Acetyl-CoA transferase 2 inhibitor | 0.053 0.048 DB00624 0.079 0.011 DBMET03460 0.103 0.005 DBMET03459 0.08 0.01 DBMET00558 0.117 0.004 DBMET02381 0.117 0.004 DBMET02382 0.117 0.004 DBMET02833 0.117 0.004 DBMET02834 | DBMET02834 | |
| 0.068 | 0.007 | 0.083 | Microtubule stabilization | 0.071 0.006 DB00624 0.042 0.038 DBMET03460 0.073 0.005 DBMET03459 0.078 0.004 DBMET00558 0.083 0.004 DBMET02381 0.083 0.004 DBMET02382 0.064 0.01 DBMET00571 0.083 0.004 DBMET02833 0.083 0.004 DBMET02834 | DBMET02834 | |
| 0.064 | 0.005 | 0.29 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.29 0.002 DB00624 0.031 0.011 DBMET03459 0.186 0.003 DBMET00558 0.091 0.004 DBMET02381 0.091 0.004 DBMET02382 0.019 0.018 DBMET00574 0.091 0.004 DBMET02833 0.091 0.004 DBMET02834 | DB00624 | |
| 0.197 | 0.143 | 0.361 | Transcription factor STAT inhibitor | 0.295 0.059 DB00624 0.219 0.113 DBMET03460 0.198 0.142 DBMET03459 0.296 0.058 DBMET00558 0.361 0.03 DBMET02381 0.361 0.03 DBMET02382 0.361 0.03 DBMET02833 0.361 0.03 DBMET02834 | DBMET02834 | |
| 0.194 | 0.143 | 0.376 | Transcription factor STAT3 inhibitor | 0.246 0.087 DB00624 0.233 0.098 DBMET03460 0.26 0.076 DBMET03459 0.325 0.042 DBMET00558 0.376 0.025 DBMET02381 0.376 0.025 DBMET02382 0.177 0.169 DBMET00571 0.376 0.025 DBMET02833 0.376 0.025 DBMET02834 | DBMET02834 | |
| 0.157 | 0.107 | 0.393 | Non-steroidal antiinflammatory agent | 0.393 0.014 DBMET03460 0.213 0.061 DBMET03459 0.172 0.094 DBMET00558 0.312 0.026 DBMET00571 | DBMET03460 | |
| 0.059 | 0.01 | 0.209 | Farnesoid X receptor agonist | 0.085 0.005 DB00624 0.053 0.013 DBMET03460 0.099 0.004 DBMET03459 0.132 0.003 DBMET00558 0.209 0.002 DBMET02381 0.209 0.002 DBMET02382 0.111 0.004 DBMET00574 0.209 0.002 DBMET02833 0.209 0.002 DBMET02834 | DBMET02834 | |
| 0.086 | 0.043 | 0.254 | Interferon agonist | 0.254 0.004 DBMET03460 0.071 0.068 DBMET03459 | DBMET03460 | |
| 0.049 | 0.008 | 0.166 | ATP citrate lysase inhibitor | 0.031 0.024 DB00624 0.166 0.003 DBMET03460 0.035 0.018 DBMET03459 | DBMET03460 | |
| 0.069 | 0.036 | 0.161 | Interferon inducer | 0.161 0.004 DBMET03460 0.061 0.052 DBMET03459 | DBMET03460 | |
| 0.132 | 0.099 | 0.324 | Protein-tyrosine phosphatase inhibitor | 0.122 0.111 DB00624 0.324 0.015 DBMET03460 0.168 0.064 DBMET03459 0.166 0.065 DBMET00558 0.168 0.064 DBMET02381 0.168 0.064 DBMET02382 0.164 0.066 DBMET00571 0.322 0.015 DBMET00574 0.168 0.064 DBMET02833 0.168 0.064 DBMET02834 | DBMET03460 | |
| 0.042 | 0.012 | 0.064 | HMG CoA reductase inhibitor | 0.039 0.016 DB00624 0.059 0.005 DBMET03460 0.043 0.011 DBMET03459 0.039 0.015 DBMET00558 0.064 0.004 DBMET02381 0.064 0.004 DBMET02382 0.064 0.004 DBMET02833 0.064 0.004 DBMET02834 | DBMET02834 | |
| 0.06 | 0.03 | 0.093 | Acetyl-CoA transferase inhibitor | 0.093 0.016 DBMET03460 0.087 0.018 DBMET03459 0.053 0.036 DBMET02381 0.053 0.036 DBMET02382 0.053 0.036 DBMET02833 0.053 0.036 DBMET02834 | DBMET03460 | |
| 0.117 | 0.089 | 0.254 | Interleukin 4 antagonist | 0.254 0.013 DBMET03460 | DBMET03460 | |
| 0.095 | 0.07 | 0.1 | Bronchodilator | 0.1 0.064 DBMET03460 0.092 0.072 DBMET03459 0.088 0.077 DBMET02381 0.088 0.077 DBMET02382 0.088 0.077 DBMET02833 0.088 0.077 DBMET02834 | DBMET03460 | |
| 0.05 | 0.026 | 0.114 | Adenylate cyclase 1 inhibitor | 0.114 0.003 DB00624 0.056 0.021 DBMET03460 0.043 0.037 DBMET03459 0.107 0.004 DBMET00558 0.109 0.004 DBMET02381 0.109 0.004 DBMET02382 0.109 0.004 DBMET02833 0.109 0.004 DBMET02834 | DB00624 | |
| 0.214 | 0.192 | 0.425 | Calcium channel activator | 0.346 0.053 DB00624 0.365 0.041 DBMET03460 0.306 0.086 DBMET03459 0.425 0.017 DBMET00558 0.388 0.029 DBMET02381 0.388 0.029 DBMET02382 0.236 0.163 DBMET00574 0.388 0.029 DBMET02833 0.388 0.029 DBMET02834 | DBMET00558 | |
| 0.088 | 0.067 | 0.534 | Alcohol dehydrogenase inhibitor | 0.098 0.055 DB00624 0.408 0.004 DBMET03460 0.527 0.003 DBMET03175 0.534 0.003 DBMET03176 | DBMET03176 | |
| 0.026 | 0.004 | 0.073 | Vitamin D receptor agonist | 0.022 0.006 DB00624 0.032 0.004 DBMET03460 0.073 0.002 DBMET03459 0.059 0.002 DBMET00558 0.07 0.002 DBMET02381 0.07 0.002 DBMET02382 0.034 0.003 DBMET00571 0.018 0.008 DBMET00574 0.07 0.002 DBMET02833 0.07 0.002 DBMET02834 | DBMET03459 | |
| 0.144 | 0.122 | 0.465 | Interleukin antagonist | 0.465 0.023 DBMET03460 0.147 0.12 DBMET03459 | DBMET03460 | |
| 0.023 | 0.002 | 0.029 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.029 0.002 DB00624 0.019 0.003 DBMET03459 0.025 0.002 DBMET00558 0.021 0.003 DBMET02381 0.021 0.003 DBMET02382 0.015 0.005 DBMET00571 0.018 0.003 DBMET00574 0.021 0.003 DBMET02833 0.021 0.003 DBMET02834 | DB00624 | |
| 0.157 | 0.137 | 0.79 | Platelet antagonist | 0.79 0.004 DBMET03460 0.172 0.124 DBMET03459 0.316 0.048 DBMET03175 0.234 0.08 DBMET00571 0.279 0.06 DBMET03176 | DBMET03460 | |
| 0.024 | 0.004 | 0.053 | Telomerase stimulant | 0.04 0.002 DB00624 0.026 0.004 DBMET03460 0.026 0.004 DBMET03459 0.042 0.002 DBMET00558 0.047 0.001 DBMET02381 0.047 0.001 DBMET02382 0.053 0.001 DBMET00571 0.016 0.013 DBMET00574 0.047 0.001 DBMET02833 0.047 0.001 DBMET02834 | DBMET00571 | |
| 0.021 | 0.001 | 0.459 | Transcortin receptor antagonist | 0.459 0 DB00624 0.018 0.001 DBMET03459 0.35 0 DBMET00558 0.201 0 DBMET02381 0.201 0 DBMET02382 0.012 0.002 DBMET00571 0.019 0.001 DBMET00574 0.201 0 DBMET02833 0.201 0 DBMET02834 | DB00624 | |
| 0.045 | 0.028 | 0.078 | Liver X receptor agonist | 0.078 0.011 DB00624 0.057 0.018 DBMET02381 0.057 0.018 DBMET02382 0.057 0.018 DBMET02833 0.057 0.018 DBMET02834 | DB00624 | |
| 0.025 | 0.01 | 0.057 | Vitamin D receptor antagonist | 0.029 0.008 DB00624 0.022 0.016 DBMET03460 0.025 0.01 DBMET03459 0.03 0.007 DBMET00558 0.057 0.004 DBMET02381 0.057 0.004 DBMET02382 0.024 0.011 DBMET00571 0.057 0.004 DBMET02833 0.057 0.004 DBMET02834 | DBMET02834 | |
| 0.052 | 0.038 | 0.135 | Protein 50S ribosomal subunit inhibitor | 0.062 0.029 DBMET03459 0.053 0.037 DBMET00558 0.054 0.036 DBMET03175 0.052 0.038 DBMET02381 0.052 0.038 DBMET02382 0.135 0.008 DBMET00571 0.052 0.038 DBMET02833 0.052 0.038 DBMET02834 0.054 0.036 DBMET03176 | DBMET00571 | |
| 0.028 | 0.015 | 0.048 | Toll-Like receptor 4 agonist | 0.034 0.008 DBMET03460 0.027 0.016 DBMET03459 0.048 0.004 DBMET03175 0.03 0.011 DBMET00571 0.037 0.006 DBMET00574 0.048 0.004 DBMET03176 | DBMET03176 | |
| 0.021 | 0.008 | 0.115 | Ileal bile acid transport inhibitor | 0.031 0.005 DB00624 0.063 0.003 DBMET03460 0.047 0.004 DBMET03459 0.063 0.003 DBMET00558 0.115 0.002 DBMET02381 0.115 0.002 DBMET02382 0.066 0.003 DBMET00571 0.015 0.014 DBMET00574 0.115 0.002 DBMET02833 0.115 0.002 DBMET02834 | DBMET02834 | |
| 0.041 | 0.029 | 0.125 | Liver X receptor alpha agonist | 0.125 0.005 DB00624 0.039 0.032 DBMET03460 0.039 0.031 DBMET00558 0.084 0.006 DBMET02381 0.084 0.006 DBMET02382 0.084 0.006 DBMET02833 0.084 0.006 DBMET02834 | DB00624 | |
| 0.038 | 0.027 | 0.059 | Vanilloid 3 antagonist | 0.059 0.005 DBMET03460 0.036 0.033 DBMET03459 | DBMET03460 | |
| 0.024 | 0.014 | 0.091 | Prostaglandin F2 alpha agonist | 0.091 0.002 DBMET03460 0.028 0.01 DBMET03459 0.024 0.014 DBMET00558 0.021 0.019 DBMET02381 0.021 0.019 DBMET02382 0.021 0.019 DBMET02833 0.021 0.019 DBMET02834 | DBMET03460 | |
| 0.08 | 0.073 | 0.117 | Interleukin 5 antagonist | 0.117 0.026 DBMET03460 | DBMET03460 | |
| 0.029 | 0.026 | 0.043 | Elastase 3A inhibitor | 0.043 0.007 DBMET03460 0.03 0.024 DBMET03459 | DBMET03460 | |
| 0.029 | 0.026 | 0.043 | Elastase 3B inhibitor | 0.043 0.007 DBMET03460 0.03 0.024 DBMET03459 | DBMET03460 | |
| 0.029 | 0.026 | 0.043 | Elastase 2B inhibitor | 0.043 0.007 DBMET03460 0.03 0.024 DBMET03459 | DBMET03460 | |
| 0.034 | 0.031 | 0.052 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.042 0.018 DB00624 0.037 0.025 DBMET03460 0.037 0.025 DBMET00558 0.052 0.01 DBMET02381 0.052 0.01 DBMET02382 0.052 0.01 DBMET02833 0.052 0.01 DBMET02834 | DBMET02834 | |
| 0.008 | 0.009 | 0.028 | Progesterone receptor A antagonist | 0.028 0.003 DB00624 | DB00624 | |
| 0.115 | 0.117 | 0.421 | Thrombolytic | 0.421 0.009 DBMET03460 0.237 0.037 DBMET00571 | DBMET03460 | |
| 0.013 | 0.016 | 0.062 | Thromboxane A2 agonist | 0.015 0.012 DB00624 0.062 0.002 DBMET03460 0.015 0.013 DBMET00558 0.021 0.005 DBMET02381 0.021 0.005 DBMET02382 0.021 0.005 DBMET02833 0.021 0.005 DBMET02834 | DBMET03460 | |
| 0.025 | 0.03 | 0.102 | Prostaglandin D2 agonist | 0.102 0.003 DBMET03460 | DBMET03460 | |
| 0.059 | 0.064 | 0.067 | Calcium channel P-type blocker | 0.065 0.04 DB00624 0.067 0.035 DBMET03460 | DBMET03460 | |
| 0.008 | 0.014 | 0.079 | Thromboxane agonist | 0.079 0.002 DBMET03460 0.012 0.006 DBMET02381 0.012 0.006 DBMET02382 0.012 0.006 DBMET02833 0.012 0.006 DBMET02834 | DBMET03460 | |
| 0.058 | 0.065 | 0.1 | Lipase inhibitor | 0.1 0.027 DBMET03460 | DBMET03460 | |
| 0.084 | 0.09 | 0.677 | Expectorant | 0.103 0.065 DB00624 0.277 0.01 DBMET03460 0.122 0.05 DBMET03459 0.153 0.034 DBMET00558 0.677 0.002 DBMET03175 0.239 0.014 DBMET02381 0.239 0.014 DBMET02382 0.341 0.006 DBMET00571 0.239 0.014 DBMET02833 0.239 0.014 DBMET02834 0.572 0.003 DBMET03176 | DBMET03175 | |
| 0.045 | 0.053 | 0.243 | GABA receptor antagonist | 0.062 0.03 DB00624 0.051 0.042 DBMET03460 0.127 0.012 DBMET03459 0.2 0.006 DBMET00558 0.243 0.005 DBMET02381 0.243 0.005 DBMET02382 0.242 0.005 DBMET00574 0.243 0.005 DBMET02833 0.243 0.005 DBMET02834 | DBMET02834 | |
| 0.053 | 0.063 | 0.15 | CDC25B inhibitor | 0.15 0.006 DBMET03460 0.064 0.045 DBMET03459 | DBMET03460 | |
| 0.147 | 0.157 | 0.324 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.142 DB00624 0.324 0.033 DBMET03460 0.203 0.091 DBMET02381 0.203 0.091 DBMET02382 0.227 0.076 DBMET00571 0.203 0.091 DBMET02833 0.203 0.091 DBMET02834 | DBMET03460 | |
| 0.04 | 0.05 | 0.085 | Parathyroid hormone antagonist | 0.05 0.022 DB00624 0.042 0.04 DBMET03459 0.054 0.016 DBMET00558 0.085 0.004 DBMET02381 0.085 0.004 DBMET02382 0.085 0.004 DBMET02833 0.085 0.004 DBMET02834 | DBMET02834 | |
| 0.015 | 0.026 | 0.022 | Progesterone receptor B antagonist | 0.022 0.01 DB00624 | DB00624 | |
| 0.111 | 0.122 | 0.157 | Acetylcholine M1 receptor antagonist | 0.157 0.068 DBMET03460 0.116 0.115 DBMET02381 0.116 0.115 DBMET02382 0.116 0.115 DBMET02833 0.116 0.115 DBMET02834 | DBMET03460 | |
| 0.001 | 0.013 | 0.004 | Vitamin D-like | 0.004 0.003 DBMET02381 0.004 0.003 DBMET02382 0.004 0.003 DBMET02833 0.004 0.003 DBMET02834 | DBMET02834 | |
| 0.114 | 0.126 | 0.39 | Hemostatic | 0.232 0.024 DBMET03460 0.127 0.101 DBMET03459 0.119 0.116 DBMET02381 0.119 0.116 DBMET02382 0.39 0.008 DBMET00571 0.358 0.011 DBMET00574 0.119 0.116 DBMET02833 0.119 0.116 DBMET02834 | DBMET00571 | |
| 0.014 | 0.027 | 0.106 | Prostaglandin EP2 agonist | 0.106 0.003 DBMET03460 | DBMET03460 | |
| 0.075 | 0.089 | 0.2 | Vanilloid agonist | 0.2 0.007 DBMET03460 | DBMET03460 | |
| 0.023 | 0.037 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET03460 0.029 0.017 DBMET00571 0.034 0.008 DBMET00574 | DBMET00574 | |
| 0.058 | 0.073 | 0.333 | Glutamate (mGluR6) antagonist | 0.064 0.054 DB00624 0.333 0.002 DBMET03460 0.066 0.047 DBMET00558 0.082 0.022 DBMET02381 0.082 0.022 DBMET02382 0.082 0.022 DBMET02833 0.082 0.022 DBMET02834 | DBMET03460 | |
| 0.02 | 0.035 | 0.057 | Vanilloid 2 agonist | 0.057 0.002 DBMET03460 0.025 0.019 DBMET02381 0.025 0.019 DBMET02382 0.034 0.006 DBMET00571 0.025 0.019 DBMET02833 0.025 0.019 DBMET02834 | DBMET03460 | |
| 0.028 | 0.046 | 0.053 | Tubulin agonist | 0.044 0.011 DB00624 0.032 0.029 DBMET03459 0.053 0.007 DBMET00558 0.053 0.007 DBMET02381 0.053 0.007 DBMET02382 0.034 0.025 DBMET00571 0.053 0.007 DBMET02833 0.053 0.007 DBMET02834 | DBMET02834 | |
| 0.033 | 0.051 | 0.118 | Adenosine deaminase inhibitor | 0.048 0.032 DB00624 0.092 0.007 DBMET03460 0.114 0.004 DBMET03175 0.118 0.004 DBMET03176 | DBMET03176 | |
| 0.021 | 0.041 | 0.197 | Prostaglandin agonist | 0.197 0.003 DBMET03460 | DBMET03460 | |
| 0.084 | 0.105 | 0.25 | Mucolytic | 0.105 0.071 DB00624 0.25 0.006 DBMET03460 0.118 0.056 DBMET03459 0.144 0.036 DBMET00558 0.23 0.008 DBMET03175 0.202 0.013 DBMET02381 0.202 0.013 DBMET02382 0.147 0.034 DBMET00571 0.202 0.013 DBMET02833 0.202 0.013 DBMET02834 0.185 0.017 DBMET03176 | DBMET03460 | |
| 0.03 | 0.051 | 0.05 | Acetyl-CoA transferase 1 inhibitor | 0.05 0.017 DBMET03460 0.037 0.035 DBMET03459 | DBMET03460 | |
| 0.039 | 0.061 | 0.213 | GABA A receptor antagonist | 0.053 0.037 DB00624 0.11 0.014 DBMET03459 0.166 0.007 DBMET00558 0.213 0.005 DBMET02381 0.213 0.005 DBMET02382 0.183 0.006 DBMET00574 0.213 0.005 DBMET02833 0.213 0.005 DBMET02834 | DBMET02834 | |
| 0.049 | 0.072 | 0.24 | Prostaglandin F2 alpha antagonist | 0.24 0.003 DBMET03460 | DBMET03460 | |
| 0.008 | 0.031 | 0.137 | Prostacyclin agonist | 0.137 0.003 DBMET03460 | DBMET03460 | |
| 0.03 | 0.053 | 0.091 | Opioid kappa receptor agonist | 0.064 0.016 DBMET03459 0.091 0.01 DBMET00558 0.053 0.022 DBMET02381 0.053 0.022 DBMET02382 0.039 0.035 DBMET00571 0.043 0.03 DBMET00574 0.053 0.022 DBMET02833 0.053 0.022 DBMET02834 | DBMET00558 | |
| 0.077 | 0.102 | 0.195 | Glutamate release inhibitor | 0.097 0.047 DB00624 0.195 0.005 DBMET03460 0.085 0.074 DBMET00558 0.097 0.048 DBMET02381 0.097 0.048 DBMET02382 0.107 0.033 DBMET00571 0.097 0.048 DBMET02833 0.097 0.048 DBMET02834 | DBMET03460 | |
| 0.004 | 0.031 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 DBMET00571 | DBMET00571 | |
| 0.129 | 0.157 | 0.885 | Succinate dehydrogenase inhibitor | 0.885 0.002 DBMET03460 | DBMET03460 | |
| 0.028 | 0.056 | 0.221 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.081 0.015 DB00624 0.076 0.017 DBMET03459 0.183 0.005 DBMET00558 0.221 0.004 DBMET02381 0.221 0.004 DBMET02382 0.045 0.035 DBMET00574 0.221 0.004 DBMET02833 0.221 0.004 DBMET02834 | DBMET02834 | |
| 0.021 | 0.051 | 0.039 | Liver X receptor beta agonist | 0.039 0.016 DB00624 0.031 0.026 DBMET03460 | DB00624 | |
| 0.082 | 0.115 | 0.102 | Acetylcholine muscarinic antagonist | 0.102 0.088 DBMET03460 0.096 0.095 DBMET02381 0.096 0.095 DBMET02382 0.096 0.095 DBMET02833 0.096 0.095 DBMET02834 | DBMET03460 | |
| 0.036 | 0.069 | 0.242 | Glucose-6-phosphate isomerase inhibitor | 0.242 0.001 DBMET03460 0.044 0.041 DBMET03459 0.051 0.028 DBMET00558 0.058 0.02 DBMET02381 0.058 0.02 DBMET02382 0.059 0.02 DBMET00571 0.058 0.02 DBMET02833 0.058 0.02 DBMET02834 | DBMET03460 | |
| 0.069 | 0.103 | 0.187 | Topoisomerase I inhibitor | 0.187 0.03 DBMET00571 | DBMET00571 | |
| 0.072 | 0.106 | 0.081 | T cell inhibitor | 0.08 0.064 DBMET03460 0.081 0.06 DBMET03459 0.081 0.06 DBMET00558 0.08 0.064 DBMET00571 | DBMET00558 | |
| 0.024 | 0.059 | 0.048 | Estrogen-related receptor beta antagonist | 0.047 0.006 DB00624 0.042 0.009 DBMET00558 0.048 0.006 DBMET02381 0.048 0.006 DBMET02382 0.048 0.006 DBMET02833 0.048 0.006 DBMET02834 | DBMET02834 | |
| 0.068 | 0.104 | 0.09 | Breast cancer-resistant protein inhibitor | 0.082 0.078 DB00624 0.085 0.072 DBMET00558 0.09 0.066 DBMET00574 | DBMET00574 | |
| 0.061 | 0.097 | 0.122 | Opioid kappa receptor antagonist | 0.073 0.071 DB00624 0.094 0.041 DBMET03459 0.122 0.023 DBMET00558 | DBMET00558 | |
| 0.085 | 0.123 | 0.169 | Electron transport complex I inhibitor | 0.169 0.013 DBMET03460 | DBMET03460 | |
| 0.04 | 0.078 | 0.19 | Heparanase inhibitor | 0.078 0.007 DBMET03460 0.061 0.021 DBMET03459 0.06 0.023 DBMET00558 0.076 0.008 DBMET02381 0.076 0.008 DBMET02382 0.19 0.002 DBMET00571 0.108 0.004 DBMET00574 0.076 0.008 DBMET02833 0.076 0.008 DBMET02834 | DBMET00571 | |
| 0.005 | 0.044 | 0.082 | Lysophosphatidic acid receptor 3 agonist | 0.082 0.002 DBMET03460 | DBMET03460 | |
| 0.017 | 0.056 | 0.06 | Thyroid hormone agonist | 0.06 0.004 DBMET03460 | DBMET03460 | |
| 0.018 | 0.058 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.021 DBMET03460 | DBMET03460 | |
| 0.016 | 0.056 | 0.101 | Lysophosphatidic acid receptor 1 agonist | 0.101 0.002 DBMET03460 | DBMET03460 | |
| 0.027 | 0.068 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.057 0.003 DBMET03460 | DBMET03460 | |
| 0.06 | 0.102 | 0.141 | Vanilloid 4 agonist | 0.141 0.004 DBMET03460 | DBMET03460 | |
| 0.014 | 0.059 | 0.054 | Retinoid X beta receptor antagonist | 0.054 0.002 DBMET03460 | DBMET03460 | |
| 0.047 | 0.097 | 0.097 | Ryanodine receptor antagonist | 0.097 0.004 DBMET03460 | DBMET03460 | |
| 0.015 | 0.067 | 0.029 | Liver X receptor antagonist | 0.029 0.024 DBMET03460 | DBMET03460 | |
| 0.011 | 0.063 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.011 DBMET00558 | DBMET00558 | |
| 0.033 | 0.086 | 0.129 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET03460 0.129 0.015 DBMET00574 | DBMET00574 | |
| 0.022 | 0.075 | 0.052 | Carboxypeptidase B inhibitor | 0.052 0.006 DBMET03460 | DBMET03460 | |
| 0.039 | 0.092 | 0.131 | Botulinum neurotoxin type A inhibitor | 0.052 0.051 DB00624 0.06 0.037 DBMET03460 0.094 0.011 DBMET03459 0.123 0.006 DBMET00558 0.131 0.005 DBMET02381 0.131 0.005 DBMET02382 0.131 0.005 DBMET02833 0.131 0.005 DBMET02834 | DBMET02834 | |
| 0.023 | 0.078 | 0.141 | Membrane dipeptidase inhibitor | 0.141 0.002 DBMET03460 | DBMET03460 | |
| 0.048 | 0.103 | 0.182 | Topoisomerase II alpha inhibitor | 0.182 0.018 DBMET00571 | DBMET00571 | |
| 0.006 | 0.061 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 DBMET02381 0.016 0.01 DBMET02382 0.016 0.01 DBMET02833 0.016 0.01 DBMET02834 | DBMET02834 | |
| 0.01 | 0.065 | 0.071 | Squalene synthetase inhibitor | 0.071 0.009 DBMET03460 | DBMET03460 | |
| 0.036 | 0.091 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.068 0.017 DBMET00571 | DBMET00571 | |
| 0.037 | 0.094 | 0.958 | Phosphofructokinase-1 inhibitor | 0.447 0.003 DBMET03460 0.075 0.044 DBMET00558 0.958 0 DBMET03175 0.087 0.037 DBMET02381 0.087 0.037 DBMET02382 0.152 0.018 DBMET00571 0.087 0.037 DBMET02833 0.087 0.037 DBMET02834 0.957 0 DBMET03176 | DBMET03175 | |
| 0.003 | 0.063 | 0.015 | Carboxypeptidase B2 inhibitor | 0.015 0.005 DBMET03460 | DBMET03460 | |
| 0.014 | 0.074 | 0.111 | Retinoid X receptor agonist | 0.111 0.004 DBMET03460 | DBMET03460 | |
| 0.007 | 0.071 | 0.1 | Thyroid hormone alpha antagonist | 0.1 0.004 DBMET03460 | DBMET03460 | |
| 0.007 | 0.073 | 0.144 | Prostaglandin E2 agonist | 0.144 0.003 DBMET03460 | DBMET03460 | |
| 0.012 | 0.078 | 0.028 | CYP24 inhibitor | 0.021 0.018 DB00624 0.028 0.011 DBMET02381 0.028 0.011 DBMET02382 0.028 0.011 DBMET02833 0.028 0.011 DBMET02834 | DBMET02834 | |
| 0.012 | 0.079 | 0.072 | Protein 30S ribosomal subunit inhibitor | 0.072 0.005 DBMET00571 | DBMET00571 | |
| 0.063 | 0.13 | 0.098 | ATPase (Vacuolar H+) inhibitor | 0.098 0.043 DBMET03460 0.098 0.042 DBMET00571 | DBMET00571 | |
| 0.073 | 0.143 | 0.988 | Adenylate kinase inhibitor | 0.44 0.002 DBMET03460 0.099 0.069 DBMET00558 0.988 0 DBMET03175 0.11 0.053 DBMET02381 0.11 0.053 DBMET02382 0.11 0.053 DBMET02833 0.11 0.053 DBMET02834 0.979 0 DBMET03176 | DBMET03175 | |
| 0.02 | 0.09 | 0.06 | Ceramide glucosyltransferase inhibitor | 0.04 0.017 DB00624 0.051 0.006 DBMET03460 0.042 0.015 DBMET00558 0.06 0.004 DBMET02381 0.06 0.004 DBMET02382 0.06 0.004 DBMET02833 0.06 0.004 DBMET02834 | DBMET02834 | |
| 0.173 | 0.243 | 0.525 | Antiobesity | 0.245 0.161 DB00624 0.245 0.162 DBMET03460 0.213 0.194 DBMET03459 0.308 0.111 DBMET00558 0.525 0.032 DBMET02381 0.525 0.032 DBMET02382 0.235 0.171 DBMET00571 0.237 0.169 DBMET00574 0.525 0.032 DBMET02833 0.525 0.032 DBMET02834 | DBMET02834 | |
| 0.041 | 0.112 | 0.084 | Adenine nucleotide translocase inhibitor | 0.084 0.008 DBMET03460 0.062 0.025 DBMET03175 0.054 0.044 DBMET00571 0.077 0.011 DBMET00574 0.062 0.024 DBMET03176 | DBMET03460 | |
| 0.106 | 0.178 | 0.14 | Tumour necrosis factor antagonist | 0.14 0.114 DBMET03460 | DBMET03460 | |
| 0.157 | 0.229 | 0.769 | Angiogenesis inhibitor | 0.222 0.146 DB00624 0.212 0.156 DBMET00558 0.218 0.15 DBMET02381 0.218 0.15 DBMET02382 0.276 0.106 DBMET00571 0.769 0.005 DBMET00574 0.218 0.15 DBMET02833 0.218 0.15 DBMET02834 | DBMET00574 | |
| 0.015 | 0.088 | 0.04 | Retinoid X gamma receptor antagonist | 0.04 0.005 DBMET03460 | DBMET03460 | |
| 0.012 | 0.085 | 0.032 | Retinoic acid receptor agonist | 0.032 0.009 DBMET03460 | DBMET03460 | |
| 0.028 | 0.102 | 0.361 | Argininosuccinate synthase inhibitor | 0.361 0.003 DBMET03460 0.063 0.034 DBMET00558 0.312 0.004 DBMET03175 0.321 0.004 DBMET03176 | DBMET03460 | |
| 0.044 | 0.119 | 0.108 | Epoxide hydrolase inhibitor | 0.108 0.021 DBMET03460 0.071 0.052 DBMET02381 0.071 0.052 DBMET02382 0.071 0.052 DBMET02833 0.071 0.052 DBMET02834 | DBMET03460 | |
| 0.02 | 0.096 | 0.086 | GABA uptake inhibitor | 0.035 0.034 DB00624 0.086 0.004 DBMET03460 0.058 0.011 DBMET00558 0.078 0.005 DBMET02381 0.078 0.005 DBMET02382 0.078 0.005 DBMET02833 0.078 0.005 DBMET02834 | DBMET03460 | |
| 0.04 | 0.117 | 0.096 | Neuraminidase (influenza) inhibitor | 0.096 0.017 DBMET03460 0.062 0.049 DBMET00571 0.068 0.038 DBMET00574 | DBMET03460 | |
| 0.004 | 0.08 | 0.106 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.106 0.003 DBMET03460 | DBMET03460 | |
| 0.076 | 0.153 | 0.246 | TRPA1 agonist | 0.246 0.005 DBMET03460 | DBMET03460 | |
| 0.028 | 0.107 | 0.062 | Cholesterol esterase inhibitor | 0.062 0.016 DBMET03460 0.046 0.037 DBMET03459 0.055 0.023 DBMET00558 0.056 0.021 DBMET02381 0.056 0.021 DBMET02382 0.056 0.021 DBMET02833 0.056 0.021 DBMET02834 | DBMET03460 | |
| 0.062 | 0.142 | 0.083 | Thioredoxin reductase inhibitor | 0.083 0.054 DBMET03460 | DBMET03460 | |
| 0.011 | 0.091 | 0.037 | Isoleucine-tRNA ligase inhibitor | 0.037 0.004 DBMET03460 | DBMET03460 | |
| 0.009 | 0.089 | 0.067 | Retinoid X gamma receptor agonist | 0.067 0.004 DBMET03460 | DBMET03460 | |
| 0.065 | 0.145 | 0.195 | Hematopoietic | 0.195 0.01 DBMET03460 0.083 0.065 DBMET03459 0.083 0.064 DBMET00558 0.118 0.023 DBMET03175 0.116 0.024 DBMET03176 | DBMET03460 | |
| 0.008 | 0.092 | 0.053 | Retinoid X beta receptor agonist | 0.053 0.005 DBMET03460 | DBMET03460 | |
| 0.032 | 0.116 | 0.07 | Squalene epoxidase inhibitor | 0.07 0.014 DBMET03460 | DBMET03460 | |
| 0.058 | 0.148 | 0.457 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.457 0.003 DBMET03460 0.083 0.076 DBMET00558 0.102 0.052 DBMET02381 0.102 0.052 DBMET02382 0.089 0.066 DBMET00571 0.102 0.052 DBMET02833 0.102 0.052 DBMET02834 | DBMET03460 | |
| 0.061 | 0.152 | 0.11 | Nitric-oxide synthase inhibitor | 0.11 0.046 DBMET03460 | DBMET03460 | |
| 0.021 | 0.114 | 0.077 | Retinoid X receptor antagonist | 0.077 0.003 DBMET03460 | DBMET03460 | |
| 0.013 | 0.106 | 0.038 | Cholesterol ester transfer protein antagonist | 0.038 0.014 DBMET03460 | DBMET03460 | |
| 0.019 | 0.113 | 0.456 | Cholecystokinin B agonist | 0.141 0.005 DBMET03460 0.456 0.002 DBMET00574 | DBMET00574 | |
| 0.014 | 0.108 | 0.122 | Retinoid X alpha receptor agonist | 0.122 0.004 DBMET03460 | DBMET03460 | |
| 0.012 | 0.108 | 0.028 | Retinoic acid gamma receptor agonist | 0.028 0.008 DBMET03460 | DBMET03460 | |
| 0.031 | 0.128 | 0.198 | Leukotriene antagonist | 0.198 0.006 DBMET03460 | DBMET03460 | |
| 0.024 | 0.124 | 0.171 | Lysophosphatidic acid 3 receptor antagonist | 0.171 0.002 DBMET03460 | DBMET03460 | |
| 0.003 | 0.103 | 0.128 | Prostaglandin EP4 agonist | 0.128 0.003 DBMET03460 | DBMET03460 | |
| 0.019 | 0.12 | 0.064 | Retinoid X alpha receptor antagonist | 0.064 0.003 DBMET03460 | DBMET03460 | |
| 0.02 | 0.123 | 0.168 | Carbonic anhydrase inhibitor | 0.064 0.043 DBMET00558 0.069 0.041 DBMET02381 0.069 0.041 DBMET02382 0.059 0.047 DBMET00571 0.168 0.013 DBMET00574 0.069 0.041 DBMET02833 0.069 0.041 DBMET02834 | DBMET00574 | |
| 0.019 | 0.122 | 0.083 | Glutamate (mGluR3) agonist | 0.083 0.003 DBMET03460 0.031 0.025 DBMET02381 0.031 0.025 DBMET02382 0.031 0.025 DBMET02833 0.031 0.025 DBMET02834 | DBMET03460 | |
| 0.011 | 0.114 | 0.048 | Nicotinic acid receptor 2 antagonist | 0.048 0.004 DBMET03460 | DBMET03460 | |
| 0.031 | 0.137 | 0.121 | HIV-1 integrase (3'-Processing) inhibitor | 0.065 0.042 DBMET03460 0.121 0.019 DBMET00574 | DBMET00574 | |
| 0.023 | 0.13 | 0.812 | Alcohol oxidase inhibitor | 0.069 0.03 DB00624 0.812 0.003 DBMET03460 0.143 0.011 DBMET00558 0.092 0.02 DBMET02381 0.092 0.02 DBMET02382 0.092 0.02 DBMET02833 0.092 0.02 DBMET02834 | DBMET03460 | |
| 0.02 | 0.127 | 0.398 | Prostaglandin EP2 antagonist | 0.398 0.004 DBMET03460 | DBMET03460 | |
| 0.144 | 0.251 | 0.612 | Vasodilator, coronary | 0.396 0.037 DBMET03460 0.612 0.007 DBMET03175 0.26 0.125 DBMET02381 0.26 0.125 DBMET02382 0.289 0.097 DBMET00571 0.26 0.125 DBMET02833 0.26 0.125 DBMET02834 0.471 0.02 DBMET03176 | DBMET03175 | |
| 0.009 | 0.117 | 0.03 | Elastase 2 inhibitor | 0.03 0.009 DBMET03460 | DBMET03460 | |
| 0.009 | 0.117 | 0.03 | Elastase 2A inhibitor | 0.03 0.009 DBMET03460 | DBMET03460 | |
| 0.009 | 0.118 | 0.071 | Lysophosphatidic acid 1 receptor antagonist | 0.071 0.003 DBMET03460 | DBMET03460 | |
| 0.027 | 0.136 | 0.157 | Leukotriene B4 antagonist | 0.157 0.005 DBMET03460 | DBMET03460 | |
| 0.009 | 0.119 | 0.056 | Leukotriene B4 receptor 2 antagonist | 0.056 0.004 DBMET03460 | DBMET03460 | |
| 0.025 | 0.136 | 0.102 | GABA B receptor antagonist | 0.102 0.005 DBMET03460 0.074 0.007 DBMET02381 0.074 0.007 DBMET02382 0.074 0.007 DBMET02833 0.074 0.007 DBMET02834 | DBMET03460 | |
| 0.027 | 0.14 | 0.08 | HCV NS3/NS4A protease inhibitor | 0.08 0.011 DBMET03460 | DBMET03460 | |
| 0.009 | 0.123 | 0.03 | Retinoic acid beta receptor agonist | 0.03 0.005 DBMET03460 | DBMET03460 | |
| 0.032 | 0.147 | 0.067 | Vanilloid 2 antagonist | 0.067 0.016 DBMET03460 | DBMET03460 | |
| 0.036 | 0.151 | 0.143 | Phospholipase D inhibitor | 0.143 0.004 DBMET03460 0.069 0.056 DBMET03459 0.095 0.018 DBMET00558 0.141 0.004 DBMET02381 0.141 0.004 DBMET02382 0.096 0.017 DBMET00574 0.141 0.004 DBMET02833 0.141 0.004 DBMET02834 | DBMET03460 | |
| 0.013 | 0.129 | 0.037 | Estrogen-related receptor alpha antagonist | 0.032 0.023 DB00624 0.03 0.026 DBMET00558 0.037 0.019 DBMET02381 0.037 0.019 DBMET02382 0.037 0.019 DBMET02833 0.037 0.019 DBMET02834 | DBMET02834 | |
| 0.084 | 0.201 | 0.155 | Sigma receptor agonist | 0.155 0.082 DB00624 | DB00624 | |
| 0.072 | 0.188 | 0.141 | Toll-Like receptor antagonist | 0.141 0.062 DBMET03460 | DBMET03460 | |
| 0.014 | 0.131 | 0.089 | Carbonic anhydrase II inhibitor | 0.049 0.045 DBMET03459 0.067 0.031 DBMET00558 0.07 0.03 DBMET02381 0.07 0.03 DBMET02382 0.056 0.038 DBMET00571 0.089 0.022 DBMET00574 0.07 0.03 DBMET02833 0.07 0.03 DBMET02834 | DBMET00574 | |
| 0.039 | 0.156 | 0.126 | Glutamate (mGluR7) antagonist | 0.126 0.004 DBMET03460 | DBMET03460 | |
| 0.069 | 0.188 | 0.321 | Toll-Like receptor 2 antagonist | 0.321 0.004 DBMET03460 | DBMET03460 | |
| 0.024 | 0.146 | 0.142 | Alpha-mannosidase inhibitor | 0.142 0.004 DBMET03460 0.057 0.031 DBMET00558 0.071 0.016 DBMET02381 0.071 0.016 DBMET02382 0.085 0.009 DBMET00571 0.061 0.025 DBMET00574 0.071 0.016 DBMET02833 0.071 0.016 DBMET02834 | DBMET03460 | |
| 0.021 | 0.142 | 0.879 | Acyl-CoA dehydrogenase inhibitor | 0.258 0.003 DBMET03460 0.783 0 DBMET03175 0.055 0.037 DBMET02381 0.055 0.037 DBMET02382 0.055 0.037 DBMET02833 0.055 0.037 DBMET02834 0.879 0 DBMET03176 | DBMET03176 | |
| 0.043 | 0.167 | 0.194 | Carbonic anhydrase VI inhibitor | 0.194 0.014 DBMET03460 | DBMET03460 | |
| 0.017 | 0.142 | 0.038 | Delayed rectifier potassium channel blocker | 0.038 0.024 DBMET03460 | DBMET03460 | |
| 0.005 | 0.131 | 0.112 | Arginase inhibitor | 0.112 0.003 DBMET03460 | DBMET03460 | |
| 0.003 | 0.13 | 0.077 | G-protein-coupled receptor 120 agonist | 0.077 0.003 DBMET03460 | DBMET03460 | |
| 0.014 | 0.142 | 0.207 | Toll-Like receptor 2 agonist | 0.207 0.007 DBMET03460 | DBMET03460 | |
| 0.032 | 0.16 | 0.076 | Angiotensin-converting enzyme inhibitor | 0.076 0.016 DBMET03460 0.053 0.04 DBMET03175 | DBMET03460 | |
| 0.038 | 0.167 | 0.141 | Caspase 9 inhibitor | 0.141 0.007 DBMET03460 | DBMET03460 | |
| 0.03 | 0.16 | 0.046 | Heme oxygenase inhibitor | 0.046 0.02 DBMET03460 | DBMET03460 | |
| 0.006 | 0.136 | 0.021 | Retinoic acid alpha receptor antagonist | 0.021 0.013 DBMET03460 | DBMET03460 | |
| 0.03 | 0.16 | 0.33 | Sphingosine 1-phosphate receptor 5 agonist | 0.33 0.003 DBMET03460 | DBMET03460 | |
| 0.004 | 0.135 | 0.11 | Carbonic anhydrase X inhibitor | 0.11 0.001 DBMET03460 | DBMET03460 | |
| 0.004 | 0.135 | 0.11 | Carbonic anhydrase VIII inhibitor | 0.11 0.001 DBMET03460 | DBMET03460 | |
| 0.03 | 0.162 | 0.101 | Sphingosine kinase inhibitor | 0.101 0.007 DBMET03460 0.055 0.049 DBMET02381 0.055 0.049 DBMET02382 0.055 0.049 DBMET02833 0.055 0.049 DBMET02834 | DBMET03460 | |
| 0.006 | 0.139 | 0.139 | Purinergic P2Y1 agonist | 0.02 0.007 DBMET03460 0.137 0.001 DBMET03175 0.139 0.001 DBMET03176 | DBMET03176 | |
| 0.007 | 0.141 | 0.177 | Purinergic P2Y12 antagonist | 0.177 0.004 DBMET03460 0.07 0.005 DBMET03175 0.071 0.005 DBMET03176 | DBMET03460 | |
| 0.006 | 0.141 | 0.019 | Retinoic acid receptor antagonist | 0.019 0.012 DBMET03460 | DBMET03460 | |
| 0.007 | 0.142 | 0.147 | Leukotriene B4 receptor 1 antagonist | 0.147 0.003 DBMET03460 | DBMET03460 | |
| 0.052 | 0.188 | 0.18 | GABA receptor agonist | 0.143 0.04 DBMET03460 0.122 0.055 DBMET03459 0.148 0.037 DBMET00558 0.18 0.023 DBMET02381 0.18 0.023 DBMET02382 0.18 0.023 DBMET02833 0.18 0.023 DBMET02834 | DBMET02834 | |
| 0.046 | 0.183 | 0.303 | Creatine kinase inhibitor | 0.106 0.053 DB00624 0.303 0.004 DBMET03460 | DBMET03460 | |
| 0.024 | 0.161 | 0.478 | Aconitate hydratase inhibitor | 0.478 0.001 DBMET03460 | DBMET03460 | |
| 0.002 | 0.14 | 0.046 | Glutamate (mGluR6) agonist | 0.046 0.002 DBMET03460 | DBMET03460 | |
| 0.02 | 0.159 | 0.08 | Glutamate (mGluR8) antagonist | 0.08 0.004 DBMET03460 | DBMET03460 | |
| 0.014 | 0.153 | 0.069 | Dopamine D5 agonist | 0.069 0.009 DBMET03460 | DBMET03460 | |
| 0.019 | 0.158 | 0.097 | Neuraminidase inhibitor | 0.097 0.017 DBMET03460 | DBMET03460 | |
| 0.149 | 0.289 | 0.661 | Histamine release inhibitor | 0.661 0.006 DBMET03460 0.471 0.04 DBMET00571 | DBMET03460 | |
| 0.004 | 0.145 | 0.118 | Calcium-dependent phospholipase A2 inhibitor | 0.118 0.003 DBMET03460 | DBMET03460 | |
| 0.04 | 0.183 | 0.077 | Opioid antagonist | 0.077 0.074 DBMET00558 | DBMET00558 | |
| 0.037 | 0.181 | 0.123 | Leukotriene C antagonist | 0.123 0.003 DBMET03460 | DBMET03460 | |
| 0.024 | 0.168 | 0.096 | Leukotriene C4 antagonist | 0.096 0.003 DBMET03460 | DBMET03460 | |
| 0.03 | 0.174 | 0.128 | Elastase 1 inhibitor | 0.128 0.01 DBMET03460 | DBMET03460 | |
| 0.042 | 0.188 | 0.137 | GABA A receptor agonist | 0.082 0.061 DBMET03459 0.116 0.026 DBMET00558 0.137 0.018 DBMET02381 0.137 0.018 DBMET02382 0.137 0.018 DBMET02833 0.137 0.018 DBMET02834 | DBMET02834 | |
| 0.016 | 0.162 | 0.166 | Mannosidase inhibitor | 0.166 0.004 DBMET03460 0.052 0.023 DBMET02381 0.052 0.023 DBMET02382 0.071 0.011 DBMET00571 0.043 0.035 DBMET00574 0.052 0.023 DBMET02833 0.052 0.023 DBMET02834 | DBMET03460 | |
| 0.021 | 0.168 | 0.327 | Selectin antagonist | 0.204 0.011 DBMET03460 0.327 0.004 DBMET00571 0.281 0.006 DBMET00574 | DBMET00571 | |
| 0.035 | 0.183 | 0.064 | Calcium channel L-type blocker | 0.064 0.061 DBMET03460 | DBMET03460 | |
| 0.026 | 0.175 | 0.216 | Leukotriene synthesis inhibitor | 0.216 0.005 DBMET03460 | DBMET03460 | |
| 0.022 | 0.173 | 0.128 | Kainate receptor agonist | 0.128 0.002 DBMET03460 | DBMET03460 | |
| 0.018 | 0.171 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 DBMET03460 | DBMET03460 | |
| 0.043 | 0.202 | 0.204 | Topoisomerase II inhibitor | 0.204 0.032 DBMET00571 | DBMET00571 | |
| 0.008 | 0.167 | 0.036 | Neuraminidase (Influenza B) inhibitor | 0.036 0.004 DBMET03460 | DBMET03460 | |
| 0.008 | 0.167 | 0.026 | Antibiotic Anthracycline-like | 0.022 0.007 DBMET03460 0.026 0.005 DBMET00571 | DBMET00571 | |
| 0.089 | 0.249 | 0.178 | CF transmembrane conductance regulator agonist | 0.134 0.109 DB00624 0.178 0.038 DBMET03460 0.149 0.078 DBMET00558 0.156 0.066 DBMET02381 0.156 0.066 DBMET02382 0.156 0.066 DBMET02833 0.156 0.066 DBMET02834 | DBMET03460 | |
| 0.04 | 0.2 | 0.108 | Protease inhibitor | 0.108 0.058 DBMET03460 | DBMET03460 | |
| 0.007 | 0.168 | 0.159 | Leukotriene D4 antagonist | 0.159 0.004 DBMET03460 | DBMET03460 | |
| 0.097 | 0.258 | 0.278 | ATPase inhibitor | 0.214 0.027 DBMET03460 0.164 0.08 DBMET03459 0.168 0.074 DBMET00558 0.205 0.033 DBMET02381 0.205 0.033 DBMET02382 0.278 0.009 DBMET00571 0.205 0.033 DBMET02833 0.205 0.033 DBMET02834 | DBMET00571 | |
| 0.03 | 0.192 | 0.131 | Calcium antagonist | 0.131 0.029 DBMET03460 | DBMET03460 | |
| 0.008 | 0.171 | 0.056 | Liver X receptor beta antagonist | 0.056 0.007 DBMET03460 | DBMET03460 | |
| 0.01 | 0.174 | 0.092 | Geranyltranstransferase inhibitor | 0.092 0.004 DBMET03460 0.046 0.027 DBMET02381 0.046 0.027 DBMET02382 0.046 0.027 DBMET02833 0.046 0.027 DBMET02834 | DBMET03460 | |
| 0.01 | 0.174 | 0.594 | Antimetabolite | 0.16 0.011 DBMET03460 0.584 0.002 DBMET03175 0.594 0.002 DBMET03176 | DBMET03176 | |
| 0.007 | 0.172 | 0.087 | Carbonic anhydrase IV inhibitor | 0.054 0.022 DBMET03460 0.049 0.026 DBMET03459 0.087 0.009 DBMET00558 0.087 0.009 DBMET02381 0.087 0.009 DBMET02382 0.038 0.035 DBMET00574 0.087 0.009 DBMET02833 0.087 0.009 DBMET02834 | DBMET02834 | |
| 0.014 | 0.18 | 0.079 | Leukocyte elastase inhibitor | 0.079 0.013 DBMET03460 | DBMET03460 | |
| 0.013 | 0.181 | 0.141 | Thromboxane A2 antagonist | 0.141 0.004 DBMET03460 | DBMET03460 | |
| 0.009 | 0.177 | 0.435 | Fumarate hydratase inhibitor | 0.435 0.002 DBMET03460 0.29 0.003 DBMET03175 0.227 0.003 DBMET03176 | DBMET03460 | |
| 0.015 | 0.187 | 0.029 | Glucosylceramidase stimulant | 0.029 0.015 DBMET03460 | DBMET03460 | |
| 0.01 | 0.183 | 0.548 | Methylmalonyl-CoA mutase inhibitor | 0.029 0.003 DBMET03460 0.548 0 DBMET03175 0.503 0 DBMET03176 | DBMET03175 | |
| 0.027 | 0.201 | 0.056 | Transcription factor AP-1 inhibitor | 0.056 0.053 DBMET03460 | DBMET03460 | |
| 0.034 | 0.209 | 0.066 | Potassium channel large-conductance Ca-activated activator | 0.066 0.049 DBMET03460 | DBMET03460 | |
| 0.043 | 0.218 | 0.495 | UDP-glucose 4-epimerase inhibitor | 0.11 0.051 DB00624 0.227 0.015 DBMET03460 0.128 0.038 DBMET00558 0.495 0.003 DBMET03175 0.104 0.057 DBMET02381 0.104 0.057 DBMET02382 0.216 0.016 DBMET00571 0.104 0.057 DBMET02833 0.104 0.057 DBMET02834 0.48 0.003 DBMET03176 | DBMET03175 | |
| 0.061 | 0.237 | 0.416 | Cell adhesion inhibitor | 0.416 0.005 DBMET03460 0.351 0.007 DBMET00571 0.11 0.074 DBMET00574 | DBMET03460 | |
| 0.133 | 0.309 | 0.487 | Toll-Like receptor agonist | 0.487 0.034 DBMET03460 | DBMET03460 | |
| 0.008 | 0.188 | 0.073 | Caspase 2 inhibitor | 0.073 0.007 DBMET03460 | DBMET03460 | |
| 0.018 | 0.198 | 0.093 | AICAR transformylase inhibitor | 0.093 0.005 DBMET03460 0.054 0.019 DBMET03175 0.048 0.024 DBMET03176 | DBMET03460 | |
| 0.03 | 0.212 | 0.09 | Protease 3C (Human rhinovirus) inhibitor | 0.09 0.02 DBMET03460 | DBMET03460 | |
| 0.018 | 0.2 | 0.307 | Peroxisome proliferator-activated receptor gamma agonist | 0.307 0.005 DBMET03460 | DBMET03460 | |
| 0.044 | 0.228 | 0.504 | Triose-phosphate isomerase inhibitor | 0.504 0.002 DBMET03460 0.084 0.069 DBMET00558 0.085 0.068 DBMET02381 0.085 0.068 DBMET02382 0.117 0.034 DBMET00571 0.131 0.027 DBMET00574 0.085 0.068 DBMET02833 0.085 0.068 DBMET02834 | DBMET03460 | |
| 0.057 | 0.24 | 0.146 | Interleukin 12 antagonist | 0.146 0.014 DBMET03460 0.097 0.058 DBMET03459 0.116 0.033 DBMET00571 | DBMET03460 | |
| 0.034 | 0.218 | 0.674 | Glutamate dehydrogenase inhibitor | 0.514 0.003 DBMET03460 0.674 0.002 DBMET03175 0.621 0.002 DBMET03176 | DBMET03175 | |
| 0.049 | 0.234 | 0.134 | Beta amyloid protein antagonist | 0.134 0.053 DBMET03460 0.098 0.093 DBMET02381 0.098 0.093 DBMET02382 0.098 0.093 DBMET02833 0.098 0.093 DBMET02834 | DBMET03460 | |
| 0.015 | 0.199 | 0.153 | Thromboxane antagonist | 0.153 0.004 DBMET03460 | DBMET03460 | |
| 0.006 | 0.191 | 0.133 | Purinergic P2X agonist | 0.133 0.002 DBMET03175 0.13 0.002 DBMET03176 | DBMET03175 | |
| 0.021 | 0.207 | 0.445 | Catalase inhibitor | 0.445 0.003 DBMET03460 | DBMET03460 | |
| 0.003 | 0.189 | 0.076 | Peroxisome proliferator-activated receptor alpha antagonist | 0.076 0.005 DBMET03460 | DBMET03460 | |
| 0.006 | 0.194 | 0.024 | Thyroid hormone alpha agonist | 0.024 0.005 DBMET03460 | DBMET03460 | |
| 0.012 | 0.202 | 0.118 | NMDA 2C receptor antagonist | 0.118 0.011 DBMET03460 0.075 0.029 DBMET00574 | DBMET03460 | |
| 0.026 | 0.218 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | 0.059 0.028 DBMET03460 | DBMET03460 | |
| 0.047 | 0.24 | 0.154 | Proteasome inhibitor | 0.154 0.044 DBMET03460 | DBMET03460 | |
| 0.018 | 0.212 | 0.124 | Thymidine kinase inhibitor | 0.057 0.015 DBMET03460 0.124 0.005 DBMET03175 0.039 0.031 DBMET02381 0.039 0.031 DBMET02382 0.039 0.031 DBMET02833 0.039 0.031 DBMET02834 0.119 0.005 DBMET03176 | DBMET03175 | |
| 0.019 | 0.212 | 0.035 | HCV polyprotein inhibitor | 0.035 0.02 DBMET03460 | DBMET03460 | |
| 0.018 | 0.212 | 0.634 | Carbamoyl phosphate synthetase inhibitor | 0.454 0.003 DBMET03460 0.054 0.05 DBMET00558 0.634 0.001 DBMET03175 0.07 0.035 DBMET02381 0.07 0.035 DBMET02382 0.07 0.035 DBMET02833 0.07 0.035 DBMET02834 0.617 0.001 DBMET03176 | DBMET03175 | |
| 0.009 | 0.204 | 0.147 | Peroxisome proliferator-activated receptor alpha agonist | 0.147 0.006 DBMET03460 | DBMET03460 | |
| 0.018 | 0.214 | 0.118 | Glutamate (mGluR8) agonist | 0.118 0.002 DBMET03460 | DBMET03460 | |
| 0.017 | 0.22 | 0.08 | Antibiotic Aminoglycoside-like | 0.033 0.031 DBMET03175 0.08 0.004 DBMET00571 0.033 0.032 DBMET03176 | DBMET00571 | |
| 0.039 | 0.243 | 0.273 | Cystathionine beta-synthase inhibitor | 0.273 0.012 DBMET03460 | DBMET03460 | |
| 0.098 | 0.304 | 0.156 | CC chemokine 6 receptor antagonist | 0.128 0.078 DBMET00558 0.123 0.101 DBMET02381 0.123 0.101 DBMET02382 0.156 0.015 DBMET00571 0.123 0.101 DBMET02833 0.123 0.101 DBMET02834 | DBMET00571 | |
| 0.048 | 0.256 | 0.735 | Alpha-N-acetylglucosaminidase inhibitor | 0.14 0.061 DB00624 0.735 0.003 DBMET03460 0.184 0.039 DBMET00558 0.254 0.022 DBMET02381 0.254 0.022 DBMET02382 0.211 0.031 DBMET00571 0.254 0.022 DBMET02833 0.254 0.022 DBMET02834 | DBMET03460 | |
| 0.002 | 0.214 | 0.041 | Aminopeptidase A inhibitor | 0.041 0.004 DBMET03460 | DBMET03460 | |
| 0.009 | 0.221 | 0.175 | NMDA 2D receptor antagonist | 0.03 0.016 DBMET03460 0.175 0.003 DBMET00574 | DBMET00574 | |
| 0.011 | 0.226 | 0.206 | Glutamate (mGluR3) antagonist | 0.206 0.003 DBMET03460 | DBMET03460 | |
| 0.009 | 0.225 | 0.635 | Ornithine carbamoyltransferase inhibitor | 0.295 0.004 DBMET03460 0.614 0.002 DBMET03175 0.635 0.002 DBMET03176 | DBMET03176 | |
| 0.016 | 0.235 | 0.09 | Diacylglycerol O-acyltransferase inhibitor | 0.09 0.01 DBMET03460 0.057 0.028 DBMET02381 0.057 0.028 DBMET02382 0.057 0.028 DBMET02833 0.057 0.028 DBMET02834 | DBMET03460 | |
| 0.007 | 0.227 | 0.28 | Ribonucleoside-diphosphate reductase inhibitor | 0.133 0.014 DBMET03460 0.261 0.004 DBMET03175 0.28 0.004 DBMET03176 | DBMET03176 | |
| 0.007 | 0.228 | 0.362 | Ribonucleotide reductase inhibitor | 0.13 0.015 DBMET03460 0.35 0.004 DBMET03175 0.362 0.003 DBMET03176 | DBMET03176 | |
| 0.042 | 0.265 | 0.215 | Multidrug resistance-associated protein 1 inhibitor | 0.181 0.015 DBMET00571 0.215 0.008 DBMET00574 | DBMET00574 | |
| 0.038 | 0.263 | 0.202 | Glutathione S-transferase inhibitor | 0.202 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.231 | 0.118 | Prostaglandin EP3 antagonist | 0.118 0.005 DBMET03460 | DBMET03460 | |
| 0.023 | 0.251 | 0.11 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.11 0.033 DBMET03460 | DBMET03460 | |
| 0.008 | 0.236 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 DBMET03460 0.039 0.035 DBMET02381 0.039 0.035 DBMET02382 0.039 0.035 DBMET02833 0.039 0.035 DBMET02834 | DBMET03460 | |
| 0.004 | 0.235 | 0.119 | Free fatty acid receptor 1 agonist | 0.119 0.004 DBMET03460 | DBMET03460 | |
| 0.038 | 0.27 | 0.373 | GABA C receptor antagonist | 0.373 0.004 DBMET03460 | DBMET03460 | |
| 0.062 | 0.295 | 0.117 | Transcription factor STAT6 inhibitor | 0.117 0.065 DBMET03460 | DBMET03460 | |
| 0.027 | 0.266 | 0.12 | Macrophage migration inhibitory factor inhibitor | 0.12 0.025 DBMET03460 | DBMET03460 | |
| 0.105 | 0.345 | 0.317 | 15-Lipoxygenase inhibitor | 0.317 0.12 DBMET03460 | DBMET03460 | |
| 0.013 | 0.254 | 0.259 | Plasminogen activator inhibitor antagonist | 0.259 0.004 DBMET03460 | DBMET03460 | |
| 0.012 | 0.254 | 0.053 | Retinoic acid alpha receptor agonist | 0.053 0.012 DBMET03460 | DBMET03460 | |
| 0.008 | 0.251 | 0.06 | Epoxide hydrolase 1 inhibitor | 0.06 0.004 DBMET03460 | DBMET03460 | |
| 0.013 | 0.257 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.016 DBMET03460 0.028 0.014 DBMET02381 0.028 0.014 DBMET02382 0.028 0.014 DBMET02833 0.028 0.014 DBMET02834 | DBMET02834 | |
| 0.048 | 0.292 | 0.208 | EphB2 antagonist | 0.208 0.082 DBMET02381 0.208 0.082 DBMET02382 0.208 0.082 DBMET02833 0.208 0.082 DBMET02834 | DBMET02834 | |
| 0.019 | 0.264 | 0.541 | Glutamate decarboxylase inhibitor | 0.541 0.002 DBMET03460 | DBMET03460 | |
| 0.034 | 0.282 | 0.733 | GABA C receptor agonist | 0.733 0.002 DBMET03460 0.1 0.066 DBMET02381 0.1 0.066 DBMET02382 0.1 0.066 DBMET02833 0.1 0.066 DBMET02834 | DBMET03460 | |
| 0.11 | 0.36 | 0.423 | Toll-Like receptor 7 agonist | 0.423 0.051 DBMET03460 | DBMET03460 | |
| 0.025 | 0.277 | 0.125 | CD45 antagonist | 0.125 0.007 DBMET03460 | DBMET03460 | |
| 0.008 | 0.265 | 0.044 | Purinergic P2Y15 antagonist | 0.044 0.005 DBMET03460 0.03 0.017 DBMET02381 0.03 0.017 DBMET02382 0.03 0.017 DBMET02833 0.03 0.017 DBMET02834 | DBMET03460 | |
| 0.035 | 0.293 | 0.221 | Chelator | 0.221 0.021 DBMET03460 | DBMET03460 | |
| 0.002 | 0.261 | 0.079 | Purinergic P2 agonist | 0.079 0.002 DBMET03175 0.078 0.002 DBMET03176 | DBMET03175 | |
| 0.002 | 0.261 | 0.079 | Purinergic receptor agonist | 0.079 0.002 DBMET03175 0.078 0.002 DBMET03176 | DBMET03175 | |
| 0.148 | 0.41 | 0.626 | 5 Hydroxytryptamine release inhibitor | 0.626 0.008 DBMET03460 | DBMET03460 | |
| 0.006 | 0.268 | 0.114 | Sphingosine 1-phosphate receptor 1 agonist | 0.114 0.004 DBMET03460 | DBMET03460 | |
| 0.013 | 0.276 | 0.041 | Nicotinic receptor alpha3 subunit antagonist | 0.041 0.034 DBMET03460 | DBMET03460 | |
| 0.013 | 0.276 | 0.061 | Sphingosine kinase 1 inhibitor | 0.061 0.009 DBMET03460 | DBMET03460 | |
| 0.031 | 0.294 | 0.09 | Exportin-1 inhibitor | 0.09 0.015 DBMET03460 | DBMET03460 | |
| 0.006 | 0.27 | 0.115 | Prostaglandin EP4 antagonist | 0.115 0.004 DBMET03460 | DBMET03460 | |
| 0.002 | 0.267 | 0.069 | Purinergic P2Y agonist | 0.069 0.002 DBMET03175 0.068 0.002 DBMET03176 | DBMET03175 | |
| 0.036 | 0.302 | 0.215 | GABA B receptor agonist | 0.215 0.003 DBMET03460 0.094 0.021 DBMET02381 0.094 0.021 DBMET02382 0.094 0.021 DBMET02833 0.094 0.021 DBMET02834 | DBMET03460 | |
| 0.004 | 0.27 | 0.057 | G protein-coupled receptor agonist | 0.057 0.014 DBMET03460 | DBMET03460 | |
| 0.007 | 0.277 | 0.103 | Phosphorylase inhibitor | 0.055 0.028 DBMET03460 0.05 0.03 DBMET00558 0.103 0.013 DBMET03175 0.079 0.017 DBMET02381 0.079 0.017 DBMET02382 0.071 0.02 DBMET00571 0.079 0.017 DBMET02833 0.079 0.017 DBMET02834 0.091 0.014 DBMET03176 | DBMET03175 | |
| 0.008 | 0.279 | 0.09 | Nicotinic acid receptor agonist | 0.09 0.005 DBMET03460 | DBMET03460 | |
| 0.006 | 0.281 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 DBMET03460 | DBMET03460 | |
| 0.042 | 0.316 | 0.23 | Cathepsin H inhibitor | 0.23 0.016 DBMET03460 | DBMET03460 | |
| 0.002 | 0.278 | 0.04 | Carbonic anhydrase XI inhibitor | 0.04 0.002 DBMET03460 | DBMET03460 | |
| 0.008 | 0.285 | 0.069 | Calcitonin receptor agonist | 0.069 0.013 DBMET03460 | DBMET03460 | |
| 0.008 | 0.288 | 0.091 | NMDA 2A receptor antagonist | 0.091 0.016 DBMET03460 | DBMET03460 | |
| 0.015 | 0.296 | 0.073 | Nicotinic alpha4beta2 receptor antagonist | 0.073 0.057 DBMET03460 | DBMET03460 | |
| 0.015 | 0.299 | 0.16 | Thromboxane synthase inhibitor | 0.16 0.004 DBMET03460 | DBMET03460 | |
| 0.079 | 0.365 | 0.55 | Superoxide dismutase inhibitor | 0.55 0.009 DBMET03460 0.185 0.135 DBMET00574 | DBMET03460 | |
| 0.022 | 0.309 | 0.075 | Bombesin 2 receptor antagonist | 0.075 0.018 DBMET03460 | DBMET03460 | |
| 0.026 | 0.315 | 0.231 | Mediator release inhibitor | 0.231 0.011 DBMET03460 | DBMET03460 | |
| 0.003 | 0.292 | 0.024 | Nicotinic acid receptor 1 antagonist | 0.024 0.005 DBMET03460 | DBMET03460 | |
| 0.012 | 0.302 | 0.767 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.137 0.009 DBMET03460 0.767 0.001 DBMET03175 0.67 0.002 DBMET03176 | DBMET03175 | |
| 0.001 | 0.293 | 0.014 | Thyroid hormone beta agonist | 0.014 0.004 DBMET03460 | DBMET03460 | |
| 0.004 | 0.299 | 0.068 | Carbonic anhydrase I inhibitor | 0.068 0.03 DBMET00574 | DBMET00574 | |
| 0.033 | 0.331 | 0.152 | Beta glucuronidase inhibitor | 0.101 0.067 DB00624 0.091 0.086 DBMET00558 0.152 0.024 DBMET00571 | DBMET00571 | |
| 0.042 | 0.342 | 0.184 | DOPA decarboxylase inhibitor | 0.184 0.009 DBMET03460 | DBMET03460 | |
| 0.109 | 0.409 | 0.579 | Tyrosine 3 hydroxylase inhibitor | 0.579 0.003 DBMET03460 | DBMET03460 | |
| 0.016 | 0.318 | 0.127 | Sphingosine 1-phosphate receptor 3 antagonist | 0.127 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.307 | 0.103 | Peroxisome proliferator-activated receptor delta agonist | 0.103 0.005 DBMET03460 | DBMET03460 | |
| 0.005 | 0.313 | 0.023 | Adenosine A3 receptor agonist | 0.023 0.007 DBMET03175 0.023 0.007 DBMET03176 | DBMET03176 | |
| 0.004 | 0.312 | 0.103 | Purinergic P2T antagonist | 0.099 0.005 DBMET03460 0.101 0.005 DBMET03175 0.103 0.005 DBMET03176 | DBMET03176 | |
| 0.011 | 0.324 | 0.059 | Prolyl endopeptidase inhibitor | 0.059 0.026 DBMET03460 | DBMET03460 | |
| 0.101 | 0.416 | 0.586 | GABA C receptor rho-3 antagonist | 0.586 0.009 DBMET03460 | DBMET03460 | |
| 0.047 | 0.362 | 0.212 | Cyclin-dependent kinase 8 inhibitor | 0.147 0.082 DB00624 0.121 0.116 DBMET00558 0.212 0.028 DBMET02381 0.212 0.028 DBMET02382 0.212 0.028 DBMET02833 0.212 0.028 DBMET02834 | DBMET02834 | |
| 0.004 | 0.32 | 0.087 | Sphingosine 1-phosphate receptor 3 agonist | 0.087 0.008 DBMET03460 | DBMET03460 | |
| 0.01 | 0.326 | 0.092 | Carbonic anhydrase XIV inhibitor | 0.092 0.013 DBMET03460 | DBMET03460 | |
| 0.004 | 0.322 | 0.031 | Sodium/glucose cotransporter 2 inhibitor | 0.031 0.012 DBMET00571 | DBMET00571 | |
| 0.016 | 0.335 | 0.073 | CYP2A6 inhibitor | 0.073 0.056 DBMET03460 | DBMET03460 | |
| 0.02 | 0.34 | 0.209 | 5-Lipoxygenase inhibitor | 0.209 0.023 DBMET03460 | DBMET03460 | |
| 0.02 | 0.342 | 0.277 | GABA aminotransferase inhibitor | 0.277 0.004 DBMET03460 | DBMET03460 | |
| 0.01 | 0.335 | 0.028 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.028 0.018 DBMET03460 | DBMET03460 | |
| 0.035 | 0.36 | 0.638 | NADH dehydrogenase inhibitor | 0.225 0.009 DBMET03460 0.08 0.076 DBMET00558 0.638 0.002 DBMET03175 0.089 0.058 DBMET02381 0.089 0.058 DBMET02382 0.112 0.033 DBMET00571 0.089 0.058 DBMET02833 0.089 0.058 DBMET02834 0.615 0.002 DBMET03176 | DBMET03175 | |
| 0.016 | 0.342 | 0.049 | Human rhinovirus A protease inhibitor | 0.049 0.044 DBMET03460 | DBMET03460 | |
| 0.034 | 0.365 | 0.279 | Carbonic anhydrase III inhibitor | 0.279 0.007 DBMET03460 | DBMET03460 | |
| 0.014 | 0.346 | 0.037 | Adenosine uptake inhibitor | 0.037 0.018 DBMET03460 | DBMET03460 | |
| 0.007 | 0.34 | 0.254 | Lysophosphatidic acid 2 receptor antagonist | 0.254 0.003 DBMET03460 | DBMET03460 | |
| 0.017 | 0.351 | 0.209 | Aminopeptidase I inhibitor | 0.209 0.006 DBMET03460 | DBMET03460 | |
| 0.048 | 0.382 | 0.228 | Sphingosine 1-phosphate receptor 4 antagonist | 0.228 0.005 DBMET03460 | DBMET03460 | |
| 0.024 | 0.359 | 0.286 | Aminopeptidase B inhibitor | 0.286 0.009 DBMET03460 | DBMET03460 | |
| 0.006 | 0.341 | 0.034 | Caspase 8 inhibitor | 0.034 0.004 DBMET03460 | DBMET03460 | |
| 0.048 | 0.383 | 0.214 | Antiamyloidogenic | 0.214 0.091 DBMET03460 | DBMET03460 | |
| 0.026 | 0.362 | 0.574 | Ferrochelatase inhibitor | 0.574 0.002 DBMET03460 | DBMET03460 | |
| 0.01 | 0.348 | 0.168 | AMPA 4 receptor antagonist | 0.168 0.004 DBMET03460 | DBMET03460 | |
| 0.014 | 0.354 | 0.117 | Carbonic anhydrase VA inhibitor | 0.117 0.019 DBMET03460 | DBMET03460 | |
| 0.039 | 0.38 | 0.135 | NADPH oxidase inhibitor | 0.135 0.066 DBMET03460 | DBMET03460 | |
| 0.007 | 0.349 | 0.026 | Toll-Like receptor 8 agonist | 0.026 0.006 DBMET03460 | DBMET03460 | |
| 0.06 | 0.402 | 0.359 | Lipoxygenase inhibitor | 0.359 0.048 DBMET03460 | DBMET03460 | |
| 0.015 | 0.363 | 0.052 | Potassium channel (Inward rectifier) activator | 0.052 0.032 DBMET03460 | DBMET03460 | |
| 0.008 | 0.356 | 0.062 | Oxytocin agonist | 0.062 0.015 DBMET03460 | DBMET03460 | |
| 0.001 | 0.35 | 0.012 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.012 0.003 DBMET03460 | DBMET03460 | |
| 0.001 | 0.35 | 0.011 | Integrin alpha5beta6 antagonist | 0.011 0.003 DBMET03460 | DBMET03460 | |
| 0.035 | 0.384 | 0.112 | MDM2 inhibitor | 0.112 0.005 DBMET03460 | DBMET03460 | |
| 0.03 | 0.381 | 0.16 | Xanthine oxidase inhibitor | 0.16 0.031 DBMET03460 | DBMET03460 | |
| 0.013 | 0.363 | 0.7 | Porphobilinogen synthase inhibitor | 0.7 0.002 DBMET03460 | DBMET03460 | |
| 0.014 | 0.365 | 0.084 | Sphingosine kinase 2 inhibitor | 0.084 0.013 DBMET03460 0.054 0.04 DBMET02381 0.054 0.04 DBMET02382 0.054 0.04 DBMET02833 0.054 0.04 DBMET02834 | DBMET03460 | |
| 0.023 | 0.374 | 0.123 | Peroxisome proliferator-activated receptor gamma antagonist | 0.123 0.009 DBMET03460 | DBMET03460 | |
| 0.016 | 0.369 | 0.244 | NMDA receptor agonist | 0.244 0.004 DBMET03460 | DBMET03460 | |
| 0.014 | 0.367 | 0.049 | Potassium channel (ATP-sensitive) activator | 0.049 0.031 DBMET03460 | DBMET03460 | |
| 0 | 0.356 | 0.005 | Bone morphogenic protein 1 inhibitor | 0.005 0.004 DBMET03460 | DBMET03460 | |
| 0.097 | 0.453 | 0.397 | Peptidyltransferase inhibitor | 0.259 0.045 DBMET03460 0.168 0.151 DBMET00558 0.219 0.077 DBMET03175 0.216 0.08 DBMET02381 0.216 0.08 DBMET02382 0.397 0.007 DBMET00571 0.216 0.08 DBMET02833 0.216 0.08 DBMET02834 0.219 0.078 DBMET03176 | DBMET00571 | |
| 0.005 | 0.362 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.014 DBMET00571 | DBMET00571 | |
| 0.025 | 0.384 | 0.177 | Sphingomyelinase inhibitor | 0.177 0.015 DBMET03460 | DBMET03460 | |
| 0.007 | 0.369 | 0.103 | Aldose reductase inhibitor | 0.103 0.017 DBMET03460 | DBMET03460 | |
| 0.01 | 0.374 | 0.502 | Biliverdin reductase inhibitor | 0.288 0.003 DBMET03460 0.502 0.001 DBMET03175 0.48 0.001 DBMET03176 | DBMET03175 | |
| 0.031 | 0.395 | 0.313 | Electrolyte absorption antagonist | 0.313 0.004 DBMET03460 | DBMET03460 | |
| 0.034 | 0.398 | 0.136 | Granulocyte macrophage colony stimulating factor agonist | 0.136 0.009 DBMET03460 | DBMET03460 | |
| 0.012 | 0.377 | 0.265 | Sphingosine 1-phosphate receptor 4 agonist | 0.265 0.003 DBMET03460 | DBMET03460 | |
| 0.01 | 0.376 | 0.033 | Melatonin receptor 1A agonist | 0.033 0.023 DBMET03460 | DBMET03460 | |
| 0.006 | 0.373 | 0.075 | Peptide deformylase inhibitor | 0.075 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.37 | 0.099 | Lysine carboxypeptidase inhibitor | 0.099 0.004 DBMET03460 | DBMET03460 | |
| 0.005 | 0.372 | 0.022 | Integrin beta6 antagonist | 0.022 0.004 DBMET03460 | DBMET03460 | |
| 0.006 | 0.376 | 0.132 | Sphingosine 1-phosphate receptor agonist | 0.132 0.004 DBMET03460 | DBMET03460 | |
| 0.027 | 0.4 | 0.288 | GABA C receptor rho-1 antagonist | 0.288 0.004 DBMET03460 | DBMET03460 | |
| 0.011 | 0.385 | 0.124 | Carbonic anhydrase V inhibitor | 0.124 0.02 DBMET03460 | DBMET03460 | |
| 0.009 | 0.384 | 0.113 | NMDA receptor antagonist | 0.113 0.039 DBMET03460 0.108 0.042 DBMET00574 | DBMET03460 | |
| 0.013 | 0.388 | 0.069 | Cytokine production stimulant | 0.069 0.008 DBMET03460 | DBMET03460 | |
| 0.008 | 0.383 | 0.036 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.027 DBMET03460 0.036 0.022 DBMET03175 0.034 0.027 DBMET03176 | DBMET03175 | |
| 0.006 | 0.382 | 0.133 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.133 0.004 DBMET03460 | DBMET03460 | |
| 0.037 | 0.414 | 0.274 | Anticonvulsant | 0.274 0.048 DBMET03460 | DBMET03460 | |
| 0.042 | 0.419 | 0.312 | DNA methyltransferase I inhibitor | 0.312 0.022 DBMET03460 | DBMET03460 | |
| 0.016 | 0.394 | 0.083 | Beta adrenoreceptor antagonist | 0.083 0.025 DBMET03460 | DBMET03460 | |
| 0.002 | 0.38 | 0.087 | Kainate receptor 1 antagonist | 0.087 0.004 DBMET03460 | DBMET03460 | |
| 0.003 | 0.382 | 0.062 | Uridine phosphorylase inhibitor | 0.062 0.005 DBMET03460 | DBMET03460 | |
| 0.092 | 0.472 | 0.231 | Heat shock protein 70 antagonist | 0.187 0.009 DBMET03460 0.231 0.004 DBMET03175 0.219 0.005 DBMET03176 | DBMET03175 | |
| 0.006 | 0.386 | 0.037 | Nicotinic acid receptor 2 agonist | 0.037 0.023 DBMET03460 | DBMET03460 | |
| 0.039 | 0.42 | 0.547 | Peroxidase inhibitor | 0.547 0.006 DBMET03460 | DBMET03460 | |
| 0.025 | 0.408 | 0.1 | Chymotrypsin inhibitor | 0.1 0.036 DBMET03460 | DBMET03460 | |
| 0.047 | 0.432 | 0.278 | Folate antagonist | 0.278 0.004 DBMET03460 0.092 0.083 DBMET03175 0.092 0.083 DBMET03176 | DBMET03460 | |
| 0.026 | 0.412 | 0.193 | HIV-1 integrase (Overall Integration) inhibitor | 0.193 0.013 DBMET03460 | DBMET03460 | |
| 0.004 | 0.391 | 0.06 | Cholecystokinin B antagonist | 0.06 0.009 DBMET03460 0.048 0.011 DBMET00574 | DBMET03460 | |
| 0.003 | 0.391 | 0.035 | Prostaglandin EP1 antagonist | 0.035 0.009 DBMET03460 | DBMET03460 | |
| 0.002 | 0.391 | 0.053 | Prostaglandin H2 antagonist | 0.053 0.003 DBMET03460 | DBMET03460 | |
| 0.12 | 0.511 | 0.271 | Calcium channel L-type activator | 0.271 0.184 DBMET03460 | DBMET03460 | |
| 0.015 | 0.408 | 0.117 | Glutamate (mGluR group III) antagonist | 0.117 0.005 DBMET03460 | DBMET03460 | |
| 0.019 | 0.412 | 0.13 | Potassium channel (Ca-activated) activator | 0.13 0.036 DBMET03460 | DBMET03460 | |
| 0.007 | 0.402 | 0.182 | Glycine transporter 2 inhibitor | 0.182 0.006 DBMET03460 | DBMET03460 | |
| 0.005 | 0.4 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET03460 | DBMET03460 | |
| 0.004 | 0.4 | 0.041 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.041 0.012 DBMET03460 | DBMET03460 | |
| 0.005 | 0.401 | 0.018 | CXC chemokine 5 receptor antagonist | 0.018 0.012 DBMET03460 | DBMET03460 | |
| 0.009 | 0.406 | 0.06 | Dihydroorotase inhibitor | 0.06 0.016 DBMET03460 | DBMET03460 | |
| 0.007 | 0.407 | 0.122 | Glutamate (mGluR1) agonist | 0.122 0.003 DBMET03460 | DBMET03460 | |
| 0.005 | 0.406 | 0.127 | NMDA receptor subunit 3B antagonist | 0.127 0.008 DBMET03460 | DBMET03460 | |
| 0.017 | 0.418 | 0.24 | Cathepsin G inhibitor | 0.24 0.013 DBMET03460 | DBMET03460 | |
| 0.005 | 0.41 | 0.948 | Purinergic P2Y antagonist | 0.138 0.005 DBMET03460 0.941 0 DBMET03175 0.948 0 DBMET03176 | DBMET03176 | |
| 0.003 | 0.409 | 0.083 | Free fatty acid receptor 1 antagonist | 0.083 0.004 DBMET03460 | DBMET03460 | |
| 0.004 | 0.411 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.024 DBMET03460 | DBMET03460 | |
| 0.004 | 0.411 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 DBMET03460 | DBMET03460 | |
| 0.002 | 0.41 | 0.039 | Neutral endopeptidase inhibitor | 0.039 0.009 DBMET03460 | DBMET03460 | |
| 0.017 | 0.426 | 0.102 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.09 DB00624 | DB00624 | |
| 0.016 | 0.434 | 0.187 | Carbonic anhydrase XIII inhibitor | 0.187 0.016 DBMET03460 | DBMET03460 | |
| 0.009 | 0.428 | 0.053 | Benzodiazepine antagonist | 0.053 0.022 DBMET03460 | DBMET03460 | |
| 0.018 | 0.438 | 0.269 | Purinergic P2X1 antagonist | 0.151 0.007 DBMET03460 0.269 0.002 DBMET03175 0.268 0.002 DBMET03176 | DBMET03175 | |
| 0.004 | 0.426 | 0.163 | NMDA 2 receptor antagonist | 0.064 0.058 DBMET03460 0.068 0.053 DBMET02381 0.068 0.053 DBMET02382 0.163 0.014 DBMET00574 0.068 0.053 DBMET02833 0.068 0.053 DBMET02834 | DBMET00574 | |
| 0.013 | 0.434 | 0.044 | Neurokinin 2 agonist | 0.044 0.025 DBMET03460 | DBMET03460 | |
| 0.008 | 0.431 | 0.111 | Glucagon-like peptide 1 agonist | 0.111 0.017 DBMET03460 | DBMET03460 | |
| 0.004 | 0.428 | 0.127 | Prostacyclin antagonist | 0.127 0.004 DBMET03460 | DBMET03460 | |
| 0.01 | 0.434 | 0.065 | VCAM-1 antagonist | 0.065 0.005 DBMET03460 | DBMET03460 | |
| 0.01 | 0.435 | 0.065 | VCAM antagonist | 0.065 0.005 DBMET03460 | DBMET03460 | |
| 0.01 | 0.434 | 0.427 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.121 0.011 DBMET03460 0.427 0.002 DBMET03175 0.407 0.002 DBMET03176 | DBMET03175 | |
| 0.017 | 0.443 | 0.082 | Glucosylceramidase inhibitor | 0.082 0.014 DBMET03460 | DBMET03460 | |
| 0.03 | 0.457 | 0.275 | Cell wall synthesis inhibitor | 0.275 0.012 DBMET03460 0.184 0.037 DBMET00571 0.15 0.065 DBMET00574 | DBMET03460 | |
| 0.004 | 0.433 | 0.096 | NMDA receptor subunit 3A antagonist | 0.096 0.009 DBMET03460 | DBMET03460 | |
| 0.042 | 0.471 | 0.255 | GABA C receptor rho-2 antagonist | 0.255 0.011 DBMET03460 | DBMET03460 | |
| 0.014 | 0.444 | 0.154 | Sphingosine 1-phosphate receptor 1 antagonist | 0.154 0.004 DBMET03460 | DBMET03460 | |
| 0.017 | 0.449 | 0.103 | Glucagon-like peptide 1 receptor antagonist | 0.103 0.005 DBMET03460 | DBMET03460 | |
| 0.003 | 0.439 | 0.133 | Glutamate (mGluR1a) agonist | 0.133 0.003 DBMET03460 | DBMET03460 | |
| 0.015 | 0.452 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.034 DBMET03460 | DBMET03460 | |
| 0.002 | 0.44 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 DBMET03175 0.013 0.004 DBMET03176 | DBMET03175 | |
| 0.009 | 0.447 | 0.061 | p53 inhibitor | 0.061 0.009 DBMET03460 | DBMET03460 | |
| 0.013 | 0.452 | 0.05 | Neurotensin receptor antagonist | 0.05 0.028 DBMET03460 | DBMET03460 | |
| 0.003 | 0.449 | 0.108 | Glucagon receptor antagonist | 0.108 0.004 DBMET03460 | DBMET03460 | |
| 0.004 | 0.451 | 0.12 | Carbonic anhydrase VB inhibitor | 0.12 0.012 DBMET03460 | DBMET03460 | |
| 0.003 | 0.45 | 0.016 | Sodium/hydrogen exchanger inhibitor | 0.016 0.015 DBMET02381 0.016 0.015 DBMET02382 0.016 0.015 DBMET02833 0.016 0.015 DBMET02834 | DBMET02834 | |
| 0.017 | 0.465 | 0.058 | Integrin alpha1beta1 antagonist | 0.058 0.005 DBMET03460 | DBMET03460 | |
| 0.014 | 0.463 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.021 DBMET03460 | DBMET03460 | |
| 0.003 | 0.454 | 0.069 | Kynurenine 3 monooxygenase inhibitor | 0.069 0.005 DBMET03460 | DBMET03460 | |
| 0.033 | 0.484 | 0.582 | Platelet aggregation inhibitor | 0.582 0.005 DBMET03460 | DBMET03460 | |
| 0.02 | 0.471 | 0.215 | Caspase 3 inhibitor | 0.215 0.007 DBMET03460 | DBMET03460 | |
| 0.004 | 0.456 | 0.099 | Cholecystokinin antagonist | 0.099 0.008 DBMET03460 0.063 0.017 DBMET00574 | DBMET03460 | |
| 0.034 | 0.487 | 0.266 | Sphingosine 1-phosphate receptor 2 antagonist | 0.266 0.004 DBMET03460 | DBMET03460 | |
| 0.039 | 0.492 | 0.181 | Hexokinase inhibitor | 0.181 0.048 DBMET03460 0.165 0.062 DBMET03175 0.145 0.085 DBMET00571 0.159 0.068 DBMET03176 | DBMET03460 | |
| 0.005 | 0.459 | 0.024 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.024 0.005 DBMET03175 0.023 0.005 DBMET03176 | DBMET03175 | |
| 0.012 | 0.469 | 0.069 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.069 0.005 DBMET03460 | DBMET03460 | |
| 0.005 | 0.462 | 0.152 | Peroxisome proliferator-activated receptor delta antagonist | 0.152 0.005 DBMET03460 | DBMET03460 | |
| 0.014 | 0.472 | 0.108 | Urease inhibitor | 0.108 0.058 DBMET03460 | DBMET03460 | |
| 0.011 | 0.47 | 0.158 | Carbonic anhydrase stimulant | 0.158 0.01 DBMET03460 | DBMET03460 | |
| 0.035 | 0.495 | 0.64 | DNA methylase inhibitor | 0.293 0.03 DBMET03460 0.64 0.004 DBMET03175 0.622 0.004 DBMET03176 | DBMET03175 | |
| 0.001 | 0.463 | 0.02 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.02 0.004 DBMET03460 | DBMET03460 | |
| 0.01 | 0.472 | 0.065 | Beta 2 adrenoreceptor antagonist | 0.065 0.02 DBMET03460 | DBMET03460 | |
| 0.014 | 0.476 | 0.126 | Glutamate (mGluR4) antagonist | 0.126 0.004 DBMET03460 | DBMET03460 | |
| 0.007 | 0.474 | 0.088 | Matrix metalloproteinase inhibitor | 0.088 0.032 DBMET03460 | DBMET03460 | |
| 0.012 | 0.48 | 0.086 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DBMET03460 | DBMET03460 | |
| 0.001 | 0.471 | 0.162 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.048 0.009 DBMET03460 0.162 0.001 DBMET03175 0.157 0.001 DBMET03176 | DBMET03175 | |
| 0.008 | 0.48 | 0.045 | Plasmepsin II inhibitor | 0.045 0.023 DBMET03460 | DBMET03460 | |
| 0.005 | 0.478 | 0.072 | Metalloproteinase-3 inhibitor | 0.072 0.018 DBMET03460 | DBMET03460 | |
| 0.001 | 0.477 | 0.013 | Angiotensin AT2 receptor agonist | 0.013 0.005 DBMET03460 | DBMET03460 | |
| 0.003 | 0.479 | 0.086 | Urate transporter 1 inhibitor | 0.086 0.007 DBMET03460 | DBMET03460 | |
| 0.003 | 0.484 | 0.024 | Endothelin A receptor antagonist | 0.024 0.013 DBMET03460 | DBMET03460 | |
| 0.003 | 0.484 | 0.031 | Sirtuin 2 inhibitor | 0.031 0.024 DBMET03460 | DBMET03460 | |
| 0.026 | 0.507 | 0.086 | mTOR complex 2 inhibitor | 0.086 0.055 DBMET03460 | DBMET03460 | |
| 0.009 | 0.494 | 0.252 | Histidine decarboxylase inhibitor | 0.252 0.009 DBMET03460 | DBMET03460 | |
| 0.038 | 0.523 | 0.297 | Thyroid hormone antagonist | 0.297 0.095 DBMET03460 | DBMET03460 | |
| 0.048 | 0.537 | 0.235 | Sphingosine 1-phosphate receptor 5 antagonist | 0.235 0.004 DBMET03460 | DBMET03460 | |
| 0.004 | 0.493 | 0.078 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.078 0.003 DBMET03175 0.076 0.003 DBMET03176 | DBMET03175 | |
| 0.005 | 0.495 | 0.481 | NMDA 2B receptor antagonist | 0.065 0.028 DBMET02381 0.065 0.028 DBMET02382 0.481 0.003 DBMET00574 0.065 0.028 DBMET02833 0.065 0.028 DBMET02834 | DBMET00574 | |
| 0.016 | 0.507 | 0.167 | Gastric antisecretory | 0.167 0.02 DBMET03460 | DBMET03460 | |
| 0.003 | 0.501 | 0.067 | Oleamide hydrolase inhibitor | 0.067 0.017 DBMET03460 | DBMET03460 | |
| 0.004 | 0.503 | 0.044 | Matrix metalloproteinase 1 inhibitor | 0.044 0.043 DBMET03460 | DBMET03460 | |
| 0.003 | 0.503 | 0.4 | Phosphoglycerate kinase inhibitor | 0.084 0.008 DBMET03460 0.4 0.002 DBMET03175 0.393 0.002 DBMET03176 | DBMET03175 | |
| 0.016 | 0.517 | 0.395 | Aminoacyl-tRNA synthetase inhibitor | 0.095 0.051 DBMET03460 0.395 0.004 DBMET03175 0.393 0.004 DBMET03176 | DBMET03175 | |
| 0.024 | 0.525 | 0.084 | MAP kinase kinase 7 inhibitor | 0.084 0.037 DBMET03460 | DBMET03460 | |
| 0.019 | 0.52 | 0.177 | Pyruvate kinase inhibitor | 0.177 0.095 DBMET03460 | DBMET03460 | |
| 0.005 | 0.508 | 0.038 | RNA-directed RNA polymerase inhibitor | 0.038 0.02 DBMET03460 | DBMET03460 | |
| 0.015 | 0.519 | 0.06 | Dihydroorotate oxidase inhibitor | 0.06 0.029 DBMET03460 | DBMET03460 | |
| 0.028 | 0.533 | 0.218 | Alpha-glucosidase inhibitor | 0.218 0.207 DBMET00571 | DBMET00571 | |
| 0.005 | 0.509 | 0.078 | Matrix metalloproteinase (membrane-type) inhibitor | 0.078 0.021 DBMET03460 | DBMET03460 | |
| 0.002 | 0.508 | 0.017 | Integrin alphaVbeta6 antagonist | 0.017 0.007 DBMET03460 | DBMET03460 | |
| 0.029 | 0.536 | 0.111 | Phosphodiesterase 6D inhibitor | 0.111 0.035 DBMET03460 | DBMET03460 | |
| 0.036 | 0.545 | 0.267 | Thyroid hormone beta antagonist | 0.267 0.107 DBMET03460 | DBMET03460 | |
| 0.007 | 0.518 | 0.036 | Glutamate (mGluR1a) antagonist | 0.036 0.035 DBMET03460 | DBMET03460 | |
| 0 | 0.512 | 0.008 | Purinergic P2Y4 agonist | 0.008 0.002 DBMET03175 0.008 0.002 DBMET03176 | DBMET03176 | |
| 0.012 | 0.525 | 0.075 | Fatty acid synthase inhibitor | 0.075 0.022 DBMET03460 | DBMET03460 | |
| 0.005 | 0.52 | 0.03 | Dipeptidyl peptidase II inhibitor | 0.03 0.026 DBMET03460 | DBMET03460 | |
| 0.003 | 0.518 | 0.021 | Endothelin B receptor antagonist | 0.021 0.012 DBMET03460 | DBMET03460 | |
| 0.004 | 0.519 | 0.042 | Endothelin receptor antagonist | 0.042 0.012 DBMET03460 | DBMET03460 | |
| 0.01 | 0.53 | 0.072 | HIV-1 integrase inhibitor | 0.072 0.046 DBMET03460 | DBMET03460 | |
| 0.004 | 0.525 | 0.074 | Cannabinoid CB1 receptor agonist | 0.074 0.032 DBMET03460 | DBMET03460 | |
| 0.003 | 0.524 | 0.224 | Cholecystokinin agonist | 0.054 0.007 DBMET03460 0.224 0.003 DBMET00574 | DBMET00574 | |
| 0.004 | 0.525 | 0.064 | Adenosine A1 receptor agonist | 0.064 0.005 DBMET03175 0.063 0.005 DBMET03176 | DBMET03175 | |
| 0.012 | 0.534 | 0.162 | Sphingosine 1-phosphate receptor antagonist | 0.162 0.005 DBMET03460 | DBMET03460 | |
| 0.002 | 0.526 | 0.008 | Free fatty acid receptor 2 antagonist | 0.008 0.005 DBMET03460 | DBMET03460 | |
| 0.076 | 0.6 | 0.23 | Nitric-oxide synthase stimulant | 0.23 0.049 DBMET03460 | DBMET03460 | |
| 0.004 | 0.53 | 0.1 | Prostaglandin-E synthase inhibitor | 0.1 0.027 DBMET03460 | DBMET03460 | |
| 0.001 | 0.532 | 0.019 | Integrin alpha4beta1 antagonist | 0.019 0.01 DBMET03460 | DBMET03460 | |
| 0.029 | 0.563 | 0.113 | D-Ala-D-Ala ligase inhibitor | 0.113 0.018 DBMET03460 | DBMET03460 | |
| 0.007 | 0.542 | 0.048 | Aminopeptidase N inhibitor | 0.048 0.034 DBMET03460 | DBMET03460 | |
| 0.01 | 0.548 | 0.066 | Aminopeptidase microsomal inhibitor | 0.066 0.034 DBMET03460 | DBMET03460 | |
| 0.001 | 0.54 | 0.027 | Angiotensin AT1B receptor antagonist | 0.027 0.004 DBMET03460 | DBMET03460 | |
| 0.015 | 0.556 | 0.076 | Adenosine A3 receptor antagonist | 0.076 0.048 DBMET03460 | DBMET03460 | |
| 0.007 | 0.548 | 0.074 | Beta 1 adrenoreceptor antagonist | 0.074 0.022 DBMET03460 | DBMET03460 | |
| 0.001 | 0.546 | 0.012 | Integrin alphaVbeta5 antagonist | 0.012 0.006 DBMET03460 | DBMET03460 | |
| 0.003 | 0.548 | 0.125 | Kainate receptor antagonist | 0.125 0.005 DBMET03460 | DBMET03460 | |
| 0.014 | 0.561 | 0.085 | Beta 3 adrenoreceptor antagonist | 0.085 0.02 DBMET03460 | DBMET03460 | |
| 0.058 | 0.605 | 0.323 | Catenin beta inhibitor | 0.323 0.005 DBMET03460 | DBMET03460 | |
| 0.003 | 0.55 | 0.045 | Methionyl aminopeptidase 1 inhibitor | 0.045 0.008 DBMET03460 | DBMET03460 | |
| 0.049 | 0.599 | 0.268 | Neurotensin receptor agonist | 0.268 0.018 DBMET03460 | DBMET03460 | |
| 0.003 | 0.555 | 0.197 | GP IIb/IIIa receptor antagonist | 0.197 0.007 DBMET03460 | DBMET03460 | |
| 0.022 | 0.576 | 0.126 | Nav1.2 sodium channel blocker | 0.126 0.077 DBMET03460 | DBMET03460 | |
| 0.008 | 0.561 | 0.104 | Maillard reaction inhibitor | 0.104 0.015 DBMET03460 | DBMET03460 | |
| 0.005 | 0.559 | 0.119 | Macrophage elastase inhibitor | 0.119 0.007 DBMET03460 | DBMET03460 | |
| 0.001 | 0.556 | 0.014 | Adenosine A2a receptor agonist | 0.014 0.012 DBMET03460 | DBMET03460 | |
| 0.101 | 0.657 | 0.399 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.399 0.102 DBMET03460 | DBMET03460 | |
| 0.004 | 0.561 | 0.044 | Integrin alphaVbeta1 antagonist | 0.044 0.005 DBMET03460 | DBMET03460 | |
| 0.025 | 0.586 | 0.169 | 5 Hydroxytryptamine 1E antagonist | 0.169 0.167 DBMET03460 | DBMET03460 | |
| 0.005 | 0.567 | 0.041 | Histamine H2 receptor agonist | 0.041 0.032 DBMET03460 | DBMET03460 | |
| 0.013 | 0.577 | 0.075 | Autotaxin inhibitor | 0.075 0.02 DBMET03460 | DBMET03460 | |
| 0.003 | 0.568 | 0.084 | Vitronectin receptor antagonist | 0.084 0.005 DBMET03460 | DBMET03460 | |
| 0.003 | 0.569 | 0.092 | Cholecystokinin A antagonist | 0.088 0.011 DBMET03460 0.092 0.01 DBMET00574 | DBMET00574 | |
| 0.005 | 0.571 | 0.067 | Xanthine dehydrogenase inhibitor | 0.067 0.034 DBMET03460 | DBMET03460 | |
| 0.01 | 0.578 | 0.049 | Guanylate cyclase stimulant | 0.049 0.021 DBMET03460 | DBMET03460 | |
| 0.036 | 0.607 | 0.138 | DNA repair enzyme inhibitor | 0.138 0.044 DBMET03460 | DBMET03460 | |
| 0.027 | 0.599 | 0.13 | Glutamate (mGluR7) agonist | 0.13 0.022 DBMET03460 | DBMET03460 | |
| 0.015 | 0.589 | 0.148 | Nav1.6 sodium channel blocker | 0.148 0.057 DBMET03460 | DBMET03460 | |
| 0.003 | 0.577 | 0.093 | AMPA 3 receptor antagonist | 0.093 0.004 DBMET03460 | DBMET03460 | |
| 0.023 | 0.598 | 0.132 | Carbonic anhydrase XV inhibitor | 0.132 0.038 DBMET03460 | DBMET03460 | |
| 0.003 | 0.58 | 0.064 | Angiotensin AT1 receptor antagonist | 0.064 0.005 DBMET03460 | DBMET03460 | |
| 0.006 | 0.586 | 0.032 | Estrogen-related receptor gamma antagonist | 0.032 0.012 DBMET03460 | DBMET03460 | |
| 0.004 | 0.585 | 0.063 | Angiotensin II receptor antagonist | 0.063 0.004 DBMET03460 | DBMET03460 | |
| 0.006 | 0.59 | 0.057 | Endothelin-converting enzyme inhibitor | 0.057 0.026 DBMET03460 | DBMET03460 | |
| 0.004 | 0.588 | 0.034 | Integrin beta5 antagonist | 0.034 0.007 DBMET03460 | DBMET03460 | |
| 0.001 | 0.586 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET03175 0.011 0.009 DBMET03176 | DBMET03175 | |
| 0.004 | 0.591 | 0.059 | Kainate receptor 4 antagonist | 0.059 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.592 | 0.128 | NMDA receptor glycine site agonist | 0.128 0.007 DBMET03460 | DBMET03460 | |
| 0.007 | 0.595 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.032 DBMET03460 | DBMET03460 | |
| 0.002 | 0.592 | 0.072 | Dihydropteroate synthase inhibitor | 0.072 0.008 DBMET03460 | DBMET03460 | |
| 0.013 | 0.604 | 0.187 | Interleukin 1 beta converting enzyme inhibitor | 0.187 0.008 DBMET03460 | DBMET03460 | |
| 0.002 | 0.593 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.01 DBMET03460 | DBMET03460 | |
| 0.002 | 0.597 | 0.134 | Kainate receptor 2 antagonist | 0.134 0.004 DBMET03460 | DBMET03460 | |
| 0.003 | 0.597 | 0.055 | Angiotensin AT2 receptor antagonist | 0.055 0.009 DBMET03460 | DBMET03460 | |
| 0.02 | 0.617 | 0.26 | 12-Lipoxygenase inhibitor | 0.26 0.103 DBMET03460 | DBMET03460 | |
| 0.003 | 0.601 | 0.034 | LFA antagonist | 0.034 0.011 DBMET03460 | DBMET03460 | |
| 0.017 | 0.615 | 0.333 | Dual specificity phosphatase inhibitor | 0.333 0.023 DBMET03460 0.184 0.064 DBMET00574 | DBMET03460 | |
| 0.006 | 0.606 | 0.265 | Phenylalanine 4-hydroxylase inhibitor | 0.265 0.004 DBMET03460 | DBMET03460 | |
| 0.004 | 0.606 | 0.047 | Collagenase inhibitor | 0.047 0.039 DBMET03460 | DBMET03460 | |
| 0.003 | 0.606 | 0.025 | Angiotensin AT1A receptor antagonist | 0.025 0.009 DBMET03460 | DBMET03460 | |
| 0.019 | 0.625 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.026 DBMET03460 | DBMET03460 | |
| 0.017 | 0.626 | 0.175 | Antibacterial (Helicobacter pylori) | 0.175 0.03 DBMET03460 | DBMET03460 | |
| 0.014 | 0.626 | 0.087 | Corticotropin releasing factor 2 receptor antagonist | 0.087 0.012 DBMET03460 | DBMET03460 | |
| 0.023 | 0.638 | 0.202 | Histone deacetylase SIRT1 inhibitor | 0.202 0.029 DBMET03460 | DBMET03460 | |
| 0.01 | 0.626 | 0.084 | Sirtuin 1 inhibitor | 0.084 0.032 DBMET03460 | DBMET03460 | |
| 0.003 | 0.62 | 0.08 | Inosine monophosphate dehydrogenase inhibitor | 0.08 0.007 DBMET03175 0.068 0.009 DBMET03176 | DBMET03175 | |
| 0.019 | 0.636 | 0.06 | Cathepsin E inhibitor | 0.06 0.04 DBMET03460 | DBMET03460 | |
| 0.018 | 0.638 | 0.116 | Nav1.3 sodium channel blocker | 0.116 0.078 DBMET03460 | DBMET03460 | |
| 0.011 | 0.634 | 0.097 | Histamine N-methyltransferase inhibitor | 0.097 0.049 DBMET03460 | DBMET03460 | |
| 0.013 | 0.638 | 0.295 | Dual specificity phosphatase 3 inhibitor | 0.295 0.03 DBMET03460 0.189 0.067 DBMET00574 | DBMET03460 | |
| 0.004 | 0.63 | 0.064 | Integrin alphaVbeta3 antagonist | 0.064 0.004 DBMET03460 | DBMET03460 | |
| 0.006 | 0.633 | 0.044 | MAP3K5 inhibitor | 0.044 0.019 DBMET03460 | DBMET03460 | |
| 0.033 | 0.661 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.044 DBMET03460 | DBMET03460 | |
| 0.004 | 0.632 | 0.117 | Prostaglandin E2 antagonist | 0.117 0.012 DBMET03460 | DBMET03460 | |
| 0.003 | 0.633 | 0.067 | Integrin beta3 antagonist | 0.067 0.005 DBMET03460 | DBMET03460 | |
| 0.002 | 0.637 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | 0.064 0.015 DBMET03460 | DBMET03460 | |
| 0.007 | 0.643 | 0.055 | Dopamine beta hydroxylase inhibitor | 0.055 0.021 DBMET03460 | DBMET03460 | |
| 0.026 | 0.665 | 0.169 | Histone acetyltransferase inhibitor | 0.169 0.115 DBMET03460 | DBMET03460 | |
| 0.005 | 0.645 | 0.092 | Metalloproteinase-9 inhibitor | 0.092 0.037 DBMET03460 | DBMET03460 | |
| 0.002 | 0.643 | 0.029 | HCV NS5B polymerase inhibitor | 0.029 0.024 DBMET03460 | DBMET03460 | |
| 0.077 | 0.719 | 0.172 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.129 DBMET03460 | DBMET03460 | |
| 0.011 | 0.654 | 0.161 | Uric acid excretion stimulant | 0.161 0.02 DBMET03460 | DBMET03460 | |
| 0.005 | 0.654 | 0.12 | Metalloproteinase-2 inhibitor | 0.12 0.029 DBMET03460 | DBMET03460 | |
| 0.006 | 0.655 | 0.044 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.01 DBMET03460 | DBMET03460 | |
| 0.003 | 0.653 | 0.033 | Kainate receptor 3 antagonist | 0.033 0.005 DBMET03460 | DBMET03460 | |
| 0.01 | 0.66 | 0.095 | Carnitine palmitoyltransferase 1B inhibitor | 0.051 0.028 DBMET03460 0.086 0.006 DBMET03175 0.095 0.005 DBMET03176 | DBMET03176 | |
| 0.014 | 0.665 | 0.062 | Antiviral (Hepatitis D) | 0.062 0.02 DBMET03175 0.06 0.022 DBMET03176 | DBMET03175 | |
| 0.016 | 0.668 | 0.143 | Phosphodiesterase I inhibitor | 0.133 0.022 DBMET03175 0.143 0.019 DBMET03176 | DBMET03176 | |
| 0.009 | 0.661 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 DBMET03460 | DBMET03460 | |
| 0.005 | 0.659 | 0.039 | Caspase 6 inhibitor | 0.039 0.009 DBMET03460 | DBMET03460 | |
| 0.001 | 0.657 | 0.089 | AMPA 1 receptor antagonist | 0.089 0.006 DBMET03460 | DBMET03460 | |
| 0.003 | 0.659 | 0.025 | Urotensin II agonist | 0.025 0.021 DBMET03460 | DBMET03460 | |
| 0.038 | 0.695 | 0.122 | Factor V inhibitor | 0.122 0.037 DBMET03460 | DBMET03460 | |
| 0.004 | 0.662 | 0.378 | Prostaglandin antagonist | 0.378 0.004 DBMET03460 | DBMET03460 | |
| 0.003 | 0.663 | 0.088 | Thymidylate synthase inhibitor | 0.088 0.005 DBMET03460 | DBMET03460 | |
| 0.003 | 0.664 | 0.105 | Integrin alpha4 antagonist | 0.105 0.005 DBMET03460 | DBMET03460 | |
| 0.01 | 0.674 | 0.04 | Aggrecanase 1 inhibitor | 0.04 0.027 DBMET03460 | DBMET03460 | |
| 0.015 | 0.686 | 0.063 | Carbonic anhydrase II stimulant | 0.063 0.02 DBMET03460 | DBMET03460 | |
| 0.011 | 0.686 | 0.175 | Mannose-6-phosphate isomerase inhibitor | 0.175 0.046 DBMET03460 | DBMET03460 | |
| 0.018 | 0.693 | 0.18 | Nav1.4 sodium channel blocker | 0.18 0.024 DBMET03460 | DBMET03460 | |
| 0.007 | 0.683 | 0.102 | Protein kinase C gamma inhibitor | 0.102 0.073 DBMET03460 | DBMET03460 | |
| 0.003 | 0.68 | 0.049 | Kainate receptor 5 antagonist | 0.049 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.69 | 0.073 | AMPA 2 receptor antagonist | 0.073 0.008 DBMET03460 | DBMET03460 | |
| 0.014 | 0.701 | 0.208 | Thiol protease inhibitor | 0.208 0.036 DBMET03460 | DBMET03460 | |
| 0.003 | 0.69 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 DBMET03460 | DBMET03460 | |
| 0.003 | 0.691 | 0.093 | Neutrophil collagenase inhibitor | 0.093 0.025 DBMET03460 | DBMET03460 | |
| 0.003 | 0.692 | 0.161 | Cholecystokinin A agonist | 0.03 0.005 DBMET03460 0.161 0.003 DBMET00574 | DBMET00574 | |
| 0.01 | 0.701 | 0.059 | Phosphodiesterase 1C inhibitor | 0.059 0.052 DBMET03460 | DBMET03460 | |
| 0.016 | 0.707 | 0.074 | DNA helicase inhibitor | 0.074 0.014 DBMET03460 | DBMET03460 | |
| 0.002 | 0.695 | 0.048 | Carnitine palmitoyltransferase 1 inhibitor | 0.048 0.009 DBMET03460 0.032 0.028 DBMET03176 | DBMET03460 | |
| 0.006 | 0.698 | 0.024 | Complement factor 1s inhibitor | 0.024 0.021 DBMET03460 | DBMET03460 | |
| 0.002 | 0.697 | 0.051 | Carnitine palmitoyltransferase inhibitor | 0.051 0.008 DBMET03460 0.035 0.022 DBMET03176 | DBMET03460 | |
| 0.003 | 0.699 | 0.036 | Histone deacetylase 7 inhibitor | 0.036 0.026 DBMET03460 | DBMET03460 | |
| 0.007 | 0.703 | 0.058 | Histone deacetylase SIRT3 inhibitor | 0.058 0.056 DBMET03460 | DBMET03460 | |
| 0.007 | 0.704 | 0.055 | Erythropoietin receptor agonist | 0.055 0.019 DBMET03460 | DBMET03460 | |
| 0.003 | 0.7 | 0.147 | Prostaglandin D2 antagonist | 0.147 0.004 DBMET03460 | DBMET03460 | |
| 0.029 | 0.729 | 0.384 | Insulysin inhibitor | 0.384 0.025 DBMET03460 | DBMET03460 | |
| 0.002 | 0.702 | 0.028 | Calcium-sensing receptor agonist | 0.028 0.016 DBMET03460 | DBMET03460 | |
| 0.004 | 0.708 | 0.022 | ICAM 1 antagonist | 0.022 0.018 DBMET03460 | DBMET03460 | |
| 0.003 | 0.71 | 0.059 | Complement C3a chemotactic receptor antagonist | 0.059 0.022 DBMET03460 | DBMET03460 | |
| 0.003 | 0.711 | 0.046 | Nerve growth factor antagonist | 0.046 0.024 DBMET03460 | DBMET03460 | |
| 0.002 | 0.711 | 0.027 | Integrin alpha4beta7 antagonist | 0.027 0.01 DBMET03460 | DBMET03460 | |
| 0.007 | 0.717 | 0.322 | Cell adhesion molecule inhibitor | 0.322 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.717 | 0.037 | Histone deacetylase 9 inhibitor | 0.037 0.032 DBMET03460 | DBMET03460 | |
| 0.001 | 0.716 | 0.04 | Adenosine kinase inhibitor | 0.04 0.007 DBMET03175 0.037 0.008 DBMET03176 | DBMET03175 | |
| 0.007 | 0.727 | 0.144 | Falcipain 3 inhibitor | 0.144 0.039 DBMET03460 | DBMET03460 | |
| 0.003 | 0.723 | 0.062 | Dihydrofolate reductase inhibitor | 0.062 0.009 DBMET03460 | DBMET03460 | |
| 0.004 | 0.724 | 0.103 | Amidase inhibitor | 0.103 0.023 DBMET03460 | DBMET03460 | |
| 0.003 | 0.728 | 0.025 | Integrin alpha2beta1 antagonist | 0.025 0.02 DBMET03460 | DBMET03460 | |
| 0.004 | 0.731 | 0.079 | Adrenaline agonist | 0.079 0.058 DBMET03460 | DBMET03460 | |
| 0.001 | 0.73 | 0.016 | Egl nine homolog 1 inhibitor | 0.016 0.009 DBMET03460 | DBMET03460 | |
| 0.003 | 0.736 | 0.038 | Factor XIIIa inhibitor | 0.038 0.025 DBMET03460 | DBMET03460 | |
| 0.02 | 0.757 | 0.258 | Neuropeptide Y2 antagonist | 0.258 0.049 DBMET03460 | DBMET03460 | |
| 0.002 | 0.742 | 0.075 | VLA-4 antagonist | 0.075 0.008 DBMET03460 | DBMET03460 | |
| 0.005 | 0.75 | 0.056 | Integrin alpha5beta1 antagonist | 0.056 0.014 DBMET03460 | DBMET03460 | |
| 0.015 | 0.761 | 0.112 | ErbB-3 antagonist | 0.112 0.033 DBMET03460 | DBMET03460 | |
| 0.003 | 0.753 | 0.042 | Glutamate (mGluR4) agonist | 0.042 0.014 DBMET03460 | DBMET03460 | |
| 0.008 | 0.759 | 0.125 | Neuropeptide Y1 antagonist | 0.125 0.11 DBMET03460 | DBMET03460 | |
| 0.004 | 0.758 | 0.045 | Integrin alpha2 antagonist | 0.045 0.015 DBMET03460 | DBMET03460 | |
| 0.011 | 0.768 | 0.053 | CXC chemokine 1 receptor antagonist | 0.053 0.032 DBMET03460 | DBMET03460 | |
| 0.003 | 0.767 | 0.118 | Leukotriene A4 hydrolase inhibitor | 0.118 0.005 DBMET03460 | DBMET03460 | |
| 0.005 | 0.773 | 0.062 | Glutamate (mGluR group III) agonist | 0.062 0.017 DBMET03460 | DBMET03460 | |
| 0.004 | 0.774 | 0.263 | Integrin antagonist | 0.263 0.005 DBMET03460 | DBMET03460 | |
| 0.004 | 0.78 | 0.242 | Calpain inhibitor | 0.242 0.073 DBMET03460 | DBMET03460 | |
| 0.002 | 0.782 | 0.02 | Integrin beta7 antagonist | 0.02 0.014 DBMET03460 | DBMET03460 | |
| 0.003 | 0.784 | 0.091 | Glutamate receptor agonist | 0.091 0.044 DBMET03460 | DBMET03460 | |
| 0.006 | 0.796 | 0.339 | Anticoagulant | 0.245 0.04 DBMET03460 0.126 0.104 DBMET00571 0.339 0.023 DBMET00574 | DBMET00574 | |
| 0.007 | 0.803 | 0.099 | Purinergic P2Y2 antagonist | 0.099 0.004 DBMET03175 0.031 0.028 DBMET00574 0.096 0.004 DBMET03176 | DBMET03175 | |
| 0.008 | 0.806 | 0.17 | DNA directed RNA polymerase inhibitor | 0.17 0.019 DBMET03175 0.167 0.019 DBMET03176 | DBMET03175 | |
| 0.003 | 0.803 | 0.153 | Purinergic P2Y1 antagonist | 0.153 0.002 DBMET03175 0.146 0.002 DBMET03176 | DBMET03175 | |
| 0.004 | 0.81 | 0.035 | Carbonic anhydrase I stimulant | 0.035 0.03 DBMET03460 | DBMET03460 | |
| 0.004 | 0.818 | 0.281 | Calpain 2 inhibitor | 0.281 0.127 DBMET03460 | DBMET03460 | |
| 0.007 | 0.822 | 0.17 | Histone deacetylase class III inhibitor | 0.17 0.031 DBMET03460 | DBMET03460 | |
| 0.003 | 0.82 | 0.075 | Collagenase 3 inhibitor | 0.075 0.028 DBMET03460 | DBMET03460 | |
| 0.002 | 0.82 | 0.057 | AMPA receptor antagonist | 0.057 0.026 DBMET03460 | DBMET03460 | |
| 0.003 | 0.824 | 0.056 | Epithelial sodium channel blocker | 0.056 0.035 DBMET03460 | DBMET03460 | |
| 0.004 | 0.825 | 0.117 | Caspase 7 inhibitor | 0.117 0.016 DBMET03460 | DBMET03460 | |
| 0.002 | 0.822 | 0.037 | DNA gyrase subunit B inhibitor | 0.037 0.028 DBMET03460 | DBMET03460 | |
| 0.003 | 0.848 | 0.02 | Adenosine A2b receptor agonist | 0.02 0.006 DBMET03175 0.02 0.006 DBMET03176 | DBMET03176 | |
| 0.003 | 0.861 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 DBMET03460 | DBMET03460 | |
| 0.004 | 0.888 | 0.061 | HIV-1 reverse transcriptase inhibitor | 0.061 0.057 DBMET03175 0.06 0.058 DBMET03176 | DBMET03175 | |
| 0.004 | 0.892 | 0.221 | Purinergic P2 antagonist | 0.221 0.006 DBMET03175 0.216 0.006 DBMET03176 | DBMET03175 | |
| 0.005 | 0.913 | 0.205 | Purinergic P2X2 antagonist | 0.205 0.004 DBMET03175 0.203 0.004 DBMET03176 | DBMET03175 | |
| 0.004 | 0.937 | 0.123 | M17 leucyl aminopeptidase inhibitor | 0.123 0.075 DBMET03460 | DBMET03460 | |
| 0.006 | 0.981 | 0.106 | Factor IXa inhibitor | 0.106 0.009 DBMET00574 | DBMET00574 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |